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ABSTRACT 
Spermine (Spm), a potent bactericidal polyamine, exerts a strong synergistic effect with β-
lactams against methicillin-resistant Staphylococcus aureus (MRSA) in a pH-dependent manner. At high 
pH (>8) Spm is a potent nucleophile, and able to form Spm-β-lactam adduct. At physiological pH (or 
lower), Spm carries positive charges, and can bind to DNA through charge interactions. The potential of 
Spm interfering with cell wall was first investigated. A spontaneous mutant of MRSA Mu50 selected for 
Spm resistance conferred resistance to Spm/β-lactam synergy. This phenotype was due to the presence of 
a 7-bp deletion in pbpB as identified by genome resequencing and confirmed by complementation. 
Analysis of cell wall composition by HPLC revealed the combination of Spm and β-lactam can reduce the 
cross-linkage of peptidoglycan.  These two lines of evidence suggest Spm may perturb cell wall integrity 
in favor of β-lactam efficacy with PBPs as a promising target. However, from the results of microarray 
analysis and fluorescent Bocillin labeling, Spm did not appear to suppress the PBPs expression or alter 
their interactions with β-lactams. Next, transcriptome analyses reveal the genes responsive to the synergy 
effect overlap extensively with those to high Spm challenge, implying the enhanced detrimental effect of 
  
Spm facilitated by β-lactams in inhibition on cell growth. In particular the induction of iron transport and 
reduction of energy production under synergy were depicted in this study, and high dose Spm was found 
to turn off the SigB regulon. Of interest, the tetM gene encoding a ribosomal protection protein for 
tetracycline (Tc) resistance exhibited the most significant fold change and high signals by both high and 
low dose Spm. Further analysis by qRT-PCR demonstrated the tetM expression was specifically induced 
by Tc and Spm to a comparable level but not by other polyamines, suggesting a similar mode of action by 
Spm and Tc in interactions with the ribosome to initiate tetM induction. Collectively, these data indicated 
the role of Spm could be multifarious with more than one target, and a combination of Spm and β-lactams 
may inhibit growth of MRSA in a more complicated manner than just potentiating β-lactam inhibition on 
PBPs. 
  
 
 
 
 
 
INDEX WORDS: Spermine, MRSA, Synergy, β-lactams 
  
  
MOLECULAR MECHANISMS OF SPERMINE ON ITS SYNERGISTIC EFFECT WITH  
ΒETA-LACTAMS AGAINST STAPHYLOCOCCUS AUREUS 
 
 
 
by 
 
 
 
 
XIANGYU YAO 
 
 
 
 
 
 
A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy  
in the College of Arts and Sciences 
Georgia State University 
2012 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Xiangyu Yao 
2012  
  
MOLECULAR MECHANISMS OF SPERMINE ON ITS SYNERGISTIC EFFECT WITH  
ΒETA-LACTAMS AGAINST STAPHYLOCOCCUS AUREUS 
 
 
by 
 
 
XIANGYU YAO 
 
 
 
Committee Chair:  Dr. Chung-Dar Lu 
 
Committee: Dr. Phang-Cheng Tai 
Dr. Zehava Eichenbaum 
Dr. Adam Wilson 
 
 
Electronic Version Approved: 
 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
November 2012 
iv 
  
DEDICATION 
To my parents Yan Yao, Hongtao Zhao and my brother Xiangwei Yao, with love.
v 
  
ACKNOWLEDGEMENTS 
 
Though only my name appears on the cover of this dissertation, a great many people have 
contributed to its production. I owe my gratitude to all those people who have made this dissertation 
possible and because of whom my graduate experience has been one that I will cherish forever. 
My deepest gratitude is to my advisor, Dr. Chung-Dar Lu. I have been amazingly fortunate to 
have an advisor who gave me the freedom to explore on my own and at the same time the guidance to the 
right path. I am grateful to him for holding me to a high research standard and enforcing strict validations 
for each research result, and thus teaching me how to do research. I hope that one day I would become as 
good an advisor to my students as Dr. Lu has been to me. 
I would give a heartfelt, special thanks to Dr. Phang-Cheng Tai. I feel very lucky to be recruited 
in GSU by him. I am always inspired and encouraged by his passion on science, full of energy and hard 
work. Most of all his continuous encouragement, guidance and genuine caring enabled me to attend to 
life while also earning my Ph.D. Thank you Dr. Tai!  
My committee members, Dr. Zehava Eichenbaum and Dr. Adam Wilson, their insightful 
comments and constructive criticisms at different stages of my research were thought-provoking and they 
helped me focus my ideas.  
I am thankful to the people in Core Facility, especially Sonja R. Young, Hyuk-Kyu Seoh, Ping 
Jiang, for their technical assistance, expertise, and most importantly, friendship. My gratitude is also 
extended to LaTesha Warren. She was one of the first friendly faces to greet me when I began this 
doctoral program and has always been a tremendous help no matter the task or circumstance.  
I would like to acknowledge all my lab mates especially Dr. Congran Li, Dr. Weiqing He, Dr. 
Hsiuchin Yang, Dr. Chun-Kai Yang, Dr. Jinshan Jin, Dr. Ying-Hsin Hsieh, Yu-Chih Peng, Jeng-Yi Li, 
Sai Madhuri Indurthi, for their valuable discussions, support and friendship. 
vi 
  
A very special thank you to my friends Jing Wang, Jie Xu, Lei Zhong, Nan Zhao, Wen Li. They 
have been always supportive and caring. I am very glad we share so many precious memories along the 
way. Another stanch supporter Yanjia Zhao, he not only helped me sort out the GeneChip data of my 
work, but has always been encouraging with full belief. For all these, I am eternally grateful. 
Most importantly, none of this would have been possible without the love and patience of my 
family. I would like to express my heart-felt gratitude to them, for their complete faith in me, their 
tolerance of my willfulness, and their great love beyond comparison in the world. This dissertation is 
dedicated to my parents Yan Yao and Hongtao Zhao, my brother Xiangwei Yao, my sister-in law Yu 
Zhang and a twinkle in my eye, my little niece Zining Yao. 
 
 
 
 
vi 
  
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ...................................................................................................................... V 
LIST OF TABLES .................................................................................................................................... XI 
LIST OF FIGURES ................................................................................................................................ XII 
CHAPTER 1: GENERAL INTRODUCTION ......................................................................................... 1 
1.1 DISTRIBUTION AND PHYSIOLOGICAL FUNCTIONS OF POLYAMINES ............................... 1 
1.2 THE TWO MODE ACTION MODEL OF SPERMINE/POLYAMINE ............................................. 2 
1.3 TOXICITY AND METABOLISM OF SPERMINE ........................................................................... 6 
Spermine catabolism ........................................................................................................................... 6 
Spermine uptake ................................................................................................................................. 6 
1.4 SPERMINE/POLYAMINE EFFECTS ON Β-LACTAMS SUSCEPTIBILITY IN BACTERIA ....... 7 
1.5 PENICILLIN BINDING PROTEINS AND Β-LACTAM RESISTANCE .......................................... 7 
1.6 RESEARCH OVERVIEW ................................................................................................................ 10 
CHAPTER 2: A PBP2 MUTANT DEVOID OF THE TRANSPEPTIDASE DOMAIN ABOLISHES 
SPERMINE / Β-LACTAM SYNERGY IN STAPHYLOCOCCUS AUREUS MU50 ........................... 13 
2.1 INTRODUCTION............................................................................................................................. 13 
2.2 MATERIALS AND METHODS ...................................................................................................... 14 
Bacterial strains, plasmids, and growth conditions ....................................................................... 14 
Isolation of spermine-resistant mutants .......................................................................................... 14 
Genotypic characterization of spermine-resistant mutant MuM ................................................. 15 
Spermine and antibiotic susceptibility tests .................................................................................... 15 
Transcriptome analysis..................................................................................................................... 15 
Complementation of pbpB ................................................................................................................ 16 
vii 
  
PBPs profiling .................................................................................................................................... 16 
Triton X-100-induced autolysis assays ............................................................................................ 16 
Preparation of autolytic enzyme extracts ....................................................................................... 17 
Enzymatic hydrolysis of crude cell walls in vitro............................................................................ 17 
Zymographic analysis ....................................................................................................................... 17 
Preparation and analysis of extracellular protein fraction ........................................................... 18 
Electrospray ionization mass spectrometry (ESI-MS) .................................................................. 18 
2.3 RESULTS ......................................................................................................................................... 19 
Growth inhibition of Mu50 by spermine is pH-dependent ........................................................... 19 
Effects of pH on oxacillin/spermine synergy of Mu50 ................................................................... 21 
Selection and preliminary characterization of a spermine-resistant mutant MuM ................... 21 
Growth limitation of MuM by pH ................................................................................................... 22 
Loss of spermine/β-lactam and gain of spermine/vancomycin synergy in MuM ........................ 26 
Genome resequencing of MuM and Mu50 identified a genetic defect in pbpB ........................... 26 
Complementation of the spermine-resistant MuM by pbpB ......................................................... 27 
Effects of the truncated PBP2 in MuM on cell wall hydrolysis .................................................... 28 
Transcriptome analysis..................................................................................................................... 29 
2.4 DISCUSSION ................................................................................................................................... 33 
Unique phenotypic behaviors and transcriptional adaptations of MuM ..................................... 33 
Physiological functions of PBP2 ....................................................................................................... 33 
The proposed model of spermine/β-lactam synergy in S. aureus ................................................. 34 
pH sensitivity of MuM ...................................................................................................................... 35 
PBP2 is not the only Spm-resistant determinant for Spm-resistant (SpmR) mutants ................ 36 
CHAPTER 3: ANALYSIS OF SPERMINE-DEPENDENT SYNERGY WITH Β-LACTAMS ON 
CELL WALL SYNTHESIS ..................................................................................................................... 37 
viii 
  
3.1 INTRODUCTION............................................................................................................................. 37 
3.2 MATERIALS AND METHODS ...................................................................................................... 37 
Bacterial strains, plasmids, and growth conditions ....................................................................... 37 
Analysis of cell wall composition ..................................................................................................... 37 
Protein cloning, expression, and purification ................................................................................. 38 
Construction of expression-vector pBAD-HisE .............................................................................. 40 
Bocillin labeling of PBPs................................................................................................................... 40 
In vivo 14C Spm labeling of S. aureus lysate .................................................................................... 41 
14C Spm labeling of overexpressed proteins in vivo ....................................................................... 41 
14C Spm labeling of purified proteins in vitro ................................................................................. 42 
DARTS (Drug Affinity Responsive Target Stability) .................................................................... 42 
3.3 RESULTS ......................................................................................................................................... 44 
Synergy between spermine and oxacillin reduces the degree of cross linkage on cell wall ........ 44 
Spm does not affect PBPs expression .............................................................................................. 47 
Spm does not affect acylation of PBPs by Bocillin ......................................................................... 47 
Formation of Spm-PBPs conjugates ................................................................................................ 48 
No change in the trypsin digestion pattern of purified PBPs by the presence of Spm ............... 49 
3.4 DISCUSSION ................................................................................................................................... 53 
Spm may potentiate β-lactam efficacy by perturbing the functional cooperation of PBPs ....... 53 
Spm may perturb other cell wall related factors (instead of PBPs) to achieve the Spm/β-lactam 
synergy ............................................................................................................................................... 53 
CHAPTER 4: TRANSCRIPTOME ANALYSIS OF S. AUREUS IN RESPONSE TO THE 
SYNERGISTIC EFFECT OF SPERMINE AND OXACILLIN .......................................................... 55 
4.1 INTRODUCTION............................................................................................................................. 55 
4.2 MATERIALS AND METHODS ...................................................................................................... 55 
ix 
  
Transcriptional profiling conditions (for low concentration of Spm, Ox, or Spm/Ox) .............. 55 
RNA isolation .................................................................................................................................... 56 
DNA Microarrays ............................................................................................................................. 56 
4.3 RESULTS ......................................................................................................................................... 57 
Quantitative analysis of ORFs influenced by Spm, Ox, Spm+Ox ................................................ 57 
Functional classification of ORFs influenced by Spm and/or Ox ................................................. 58 
4.4 DISCUSSION ................................................................................................................................... 61 
Genes regulated by low dose Spm ................................................................................................... 61 
Gene regulated by low dose Ox ........................................................................................................ 62 
Genes regulated by the Spm/Ox combination ................................................................................ 62 
CHAPTER 5: CHARACTERIZATION OF S. AUREUS RESPONSE TO SPERMINE TOXICITY
 .................................................................................................................................................................... 65 
5.1 INTRODUCTION............................................................................................................................. 65 
5.2 MATERIAL AND METHODS ........................................................................................................ 68 
Bacterial strains, plasmids, and growth conditions ....................................................................... 68 
Transcriptional profiling conditions and microarray (for high concentration of Spm) ............. 68 
Microarray validation by quantitative reverse transcription-PCR (qRT-PCR)......................... 68 
PotR cloning, expression, and purification ..................................................................................... 69 
Construction of a potRABCD knockout mutant ............................................................................. 70 
Cloning of the speG and tetM genes ................................................................................................. 71 
Construction of promoter::GFP fusion for the pot operon ........................................................... 71 
Measurements of promoter activities .............................................................................................. 72 
Electromobility shift assays .............................................................................................................. 72 
Polyamine Uptake ............................................................................................................................. 73 
5.3 RESULTS ......................................................................................................................................... 76 
x 
  
Binding activity of Spm to DNA ...................................................................................................... 76 
Acetyltransferase SpeG affects Spm toxicity but not Spm/β-lactam synergy.............................. 76 
Transcriptome analysis of S. aureus in response to high dose Spm ............................................. 77 
Spermine-specific induction of tetM ................................................................................................ 84 
The potRABCD locus for polyamine uptake and regulation ......................................................... 87 
The kdpFABCDE locus ..................................................................................................................... 94 
5.4 DISCUSSION ................................................................................................................................... 96 
Transcriptome analysis..................................................................................................................... 96 
Spm, iron (heme) and electron-transport/energy production ....................................................... 97 
tetM ..................................................................................................................................................... 97 
How does S. aureus protect itself from Spm toxicity? ................................................................... 98 
CHAPTER 6: GENERAL CONCLUSION .......................................................................................... 100 
REFERENCES ........................................................................................................................................ 103 
APPENDICES ......................................................................................................................................... 110 
APPENDIX A: SUPPLEMENTARY DATA ....................................................................................... 110 
APPENDIX B: CHARACTERIZATION OF SPM SPONTANEOUS RESISTANT MUTANTS ...... 165 
APPENDIX C: SELECTED PUBLICATIONS .................................................................................... 173 
xi 
  
LIST OF TABLES 
Table 1. 1 pKa values of polyamines. ........................................................................................................... 5 
Table 1. 2 PBPs in MRSA .......................................................................................................................... 12 
Table 2. 1 MICs of oxacillin, vancomycin, and spermine in Mu50 and MuM. .......................................... 20 
Table 3. 1 Plasmids used in Chapter 3 ........................................................................................................ 43 
Table 5. 1 Bacterial strains and plasmids used in Chapter 5. ...................................................................... 67 
Table 5. 2 MICs of Spm and Ox in speG supplementing Mu50. ................................................................ 74 
Table 5. 3 MICs of Tc and Spm  in tetM-supplementing bacteria. ............................................................. 86 
Table 5. 4 MICs of Spm and CFZ in wild type and pot mutant. ................................................................. 92 
Table 5. 5 Effects of osmotic-shock solutions on the MICs of Spm and Ox in Mu50. .............................. 95 
Table S1 Oligonucleotides used in this study. .......................................................................................... 110 
Table S2 Transcriptome: MuM vs Mu50 (no Spm) .................................................................................. 112 
Table S3 Transcriptome: Mu50 low Spm. Ox. Spm+Ox (Assay I) .......................................................... 119 
Table S4 Transcriptome: Mu50 high Spm (Assay II) ............................................................................... 142 
Table S5 Transcriptome: RN4220 vs its SpmR mutants (no Spm) ........................................................... 157 
Table B. 1 Summary of SpmR mutants selected from different lineage of S. aureus ............................... 168 
Table B. 2 MICs of Spm or β-lactams in SpmR mutants .......................................................................... 168 
Table B. 3 Mutations identified in SpmR mutants ..................................................................................... 171 
Table B. 4 Summary of complementation experiments. ........................................................................... 171 
Table B. 5 MICs of Spm in wildtype, SpmR mutants and complementing strains. .................................. 172 
Table B. 6 Statistics of 454 genome sequencing....................................................................................... 172 
xii 
  
LIST OF FIGURES 
Figure 1. 1Schematic presentation of common polyamines and two polyamine modification reactions. .... 4 
Figure 1. 2 Summary of the ''two mode action'' model of polyamines. ........................................................ 5 
Figure 1. 3 PG synthesis and β-lactam antibiotics. ..................................................................................... 12 
Figure 2. 1 Growth inhibition by exogenous spermine. .............................................................................. 20 
Figure 2. 2 pH-dependent effects of spermine or spermine/β-lactam synergy. .......................................... 23 
Figure 2. 3 ESI mass spectrum analysis. ..................................................................................................... 24 
Figure 2. 4 Growth behaviors of Mu50 and MuM. ..................................................................................... 25 
Figure 2. 5 Identification of the pbpB lesion in spermine-resistant mutant MuM. ..................................... 31 
Figure 2. 6 Analysis of cell wall hydrolysis. ............................................................................................... 32 
Figure 3. 1 Chromatograms of peptidoglycan analysis by HPLC. ............................................................. 45 
Figure 3. 2 Transcript levels of pbp genes exposed to Spm and Ox alone or in combination. ................... 46 
Figure 3. 3 PBPs profiles of S. aureus exposed to Spm during growth. ..................................................... 46 
Figure 3. 4 Binding kinetics of Bocillin to PBPs in the presence or absence of Spm. ............................... 50 
Figure 3. 5 14C Spm labeling of proteins ..................................................................................................... 51 
Figure 3. 6 DARTs analysis with pure PBPs. ............................................................................................. 52 
Figure 4. 1 Quantification and overlaps of different treatment regulated transcriptional profiles. ............. 59 
Figure 4. 2 Biological processes that are regulated in response to Spm and Ox alone or in combination.. 60 
Figure 4. 3 Summary of transcriptome from Array I and Array II. ............................................................ 64 
Figure 5. 1 Binding of polyamines to DNA. ............................................................................................... 74 
Figure 5. 2 FIC isobologram for combinations of Spm and Ox against S.aureus Mu50. ........................... 75 
Figure 5. 3 Inhibition of growth by spermine and spermine/oxacillin combination. .................................. 75 
Figure 5. 4 Biological processes that are regulated in response to high dose spermine (>2.5 fold). .......... 78 
Figure 5. 5 Transcription profiles of representative genes influenced by high dose spermine. .................. 83 
Figure 5. 6 RT-PCR analysis of tetM in response to different polyamines. ............................................... 86 
xiii 
  
Figure 5. 7  Schematic representations of Pot system. ................................................................................ 90 
Figure 5. 8 RT-PCR analysis of potA in response to different polyamines. ............................................... 91 
Figure 5. 9 Uptake of different polyamines in wild type  and potD mutant ............................................... 91 
Figure 5. 10 Promoter activity of PpotR or PpotRA. ................................................................................... 92 
Figure 5. 11 Electromobility shift analysis of PotR-Ppot interaction. ........................................................ 93 
Figure 5. 12 Schematic representation of Kdp system. ............................................................................... 95 
Figure B. 1 Glucose effects on the growth deficient SpmR mutants. ........................................................ 169 
Figure B. 2 Growth kinetics of wildtype and SpmR mutants on exposure to Spm ................................... 170 
 
 
 
 
  
 
1 
  
CHAPTER 1: GENERAL INTRODUCTION 
 
Spermine, a ubiquitous biogenic polyamine, has been widely studied for its biological roles in the 
regulation of DNA/RNA binding (15), modulation of ion channel activity (76, 108), and as a second 
messenger in cellular signaling (108). In humans, polyamines in circulation were significantly higher in 
cancer patients, and spermine released from damaged or dead cells at inflammatory sites plays a role in 
regulation of macrophage activation (2, 124). Unlike in human, bacteria in general do not make spermine. 
Many Gram-negative bacteria possess active uptake systems for polyamines (including spermine) and 
specific catabolic pathways to utilize polyamines as nutrients for growth. But if left in excess and 
unmodified, spermine is toxic to the cells (97). Therefore, my dissertation project focused on elucidating 
the spermine-based antibacterial targets in the model pathogen Staphylococcus aureus. Particularly in 
Project I (Chapter 2, 3, and 4), I was interested in how spermine could potentiate β-lactams against 
methicillin-resistant S. aureus (MRSA), and provided evidence to support the idea that spermine may 
perturb cell wall integrity through its interactions with penicillin binding proteins (PBPs). In project II 
(Chapter 5), I performed the transciptome analysis and characterized how MRSA responds to the 
antibacterial activity of spermine per se.  
 
1.1 DISTRIBUTION AND PHYSIOLOGICAL FUNCTIONS OF POLYAMINES 
Polyamines are a group of organic cations (Figure 1.1) essential for cell growth in all living organisms. In 
general, diamine putrescine (Put) and triamine spermidine (Spd) are the two most common polyamines in 
all organisms while tetra-amine spermine (Spm) exists in eukaryotes but not in most bacteria. Some 
bacteria are capable of making other polyamines (e.g. diaminopropane, cadaverine, norspermidine) 
different from these three common ones. Because of the positive-charged nature, polyamines are believed 
2 
  
to serve as ubiquitous structural components in cells through interactions with RNA and DNA 
macromolecules (19). 
 
In humans, considerable attention has been paid to polyamine biosynthesis as a target for anti-tumor 
therapy because an elevated level of intracellular polyamine pools is a unique character of tumor cells 
(113). Many compounds have been reported to serve as inhibitors of biosynthesis, as inducers of 
catabolism, or as competitors of polyamine uptake. Spm also participates in regulation of innate immunity. 
The tissue level of Spm is significantly increased at the inflammatory sites of infection. Released from 
dying cells, Spm can restrain macrophage activation in the anti-inflammatory process by inhibiting pro-
inflammatory gene expression (124). 
 
In bacteria, it has been reported that mutant strains of Escherichia coli and Pseudomonas aeruginosa 
defective in polyamine biosynthesis exhibited a retarded growth phenotype (17, 73). Based on the studies 
in polyamine-requiring mutant strains of E. coli, the concept of “polyamine modulon” was proposed by 
Igarashi and Kashiwagi (44), referring to a group of genes whose expression requires intracellular 
polyamines for translational initiation. Exogenous polyamines may serve as environmental cues and 
participate in many other aspects of bacterial physiology including inhibition of swarming ability and 
chemotaxis (26), resistance to nitrosative stress (14), activation of biofilm formation (50), anti-mutagens 
activity (81, 82), and SOS induction of RecA and UvrA (52). As described below, exogenous polyamines 
and the cognate uptake systems also play roles in bacterial virulence and drug resistance. However, 
molecular mechanisms for many of these multifaceted polyamine effects remain unknown. 
 
1.2 THE TWO MODE ACTION MODEL OF SPERMINE/POLYAMINE 
Many of the activities of the polyamines depend on their donation of free electron pairs. On one hand, the 
amine can accept a proton to form positively charged ion, rendering the ability to interact with different 
3 
  
polyanionic molecules (mainly DNA and RNA). On the other hand, in addition to the basicity of the 
amines, defined by the removal of a proton, aliphatic amines are also characterized by their reactions with 
nitrous acid, the addition of alkyl groups, and their conversion into amides (e.g. N-acetylation) (19). 
Hence, spermine, and polyamine in general, may  potentially serve as nucleophile (the primary amino 
groups are considered most reactive) (49) to form conjugates with organic compounds or a variety of 
biomolecules. According to the pKa values (Table 1.1), under physiological pH or lower, spermine could 
acts as a base (mode I) while higher pH allows for its reactions using free amino group(s) with the 
nucleophilic property (mode II) (Figure 1.2).  
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Figure 1. 1Schematic presentation of common polyamines and two polyamine modification 
reactions. 
GPS, glutamylpolyamine synthetase;  
SSAT, spermine/spermidine acetyltransferase  
  
Glu + ATP
ADP + Pi
GPS
Acetyl-CoA
CoA
SSAT
γ-Glutamyl polyamine Acetyl polyamine
H2N–(CH2)3–NH–(CH2)4–NH2
Spermidine
H2N–(CH2)3–NH–(CH2)3–NH –(CH2)3–NH2
Norspermine
polyamines
H2N–(CH2)4–NH2
Putrescine
H2N–(CH2)3–NH2
Diaminopropane
H2N–(CH2)5–NH2
Cadaverine
H2N–(CH2)3–NH–(CH2)3–NH2
Norspermidine
H2N–(CH2)3–NH–(CH2)4–NH –(CH2)3–NH2
Spermine
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Table 1. 1 pKa values of polyamines. 
   
a Adapted from Palmer and Powell (1974) in 0.1M NaCl 
b Adapted from Gold and Powell (1976) in 0.1M NaCl 
c Adapted from Barbucci et al. (1970) in 0.5M NaNO3 
 
 
 
 
  
Figure 1. 2 Summary of the ''two mode action'' model of polyamines. 
The tetra-amine spermine was used as representative.  
PBPs, penicillin-binding proteins.  
Polyamine pKa 
Sperminea 10.80. 10.02, 8.85, 7.96 
Spermidineb 10.89, 9.81, 8.34 
Putrescinec 10.80, 9.63 
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1.3 TOXICITY AND METABOLISM OF SPERMINE 
Although polyamines are required for cell growth, these compounds in excess could be lethal to the cells 
if left unchecked. Among common polyamines in humans, spermine is the most potent bactericidal agent 
(33, 38, 97). To avoid the potential lethal effects, the cells need to maintain spermine homeostasis through 
coordinated regulation on catabolism, biosynthesis, and uptake. 
Spermine catabolism 
In both human and some bacteria, spermine catabolism can quickly attenuate the toxicity through 
modification on the amine groups, and ultimately degrade the compound. To initiate degradation, 
polyamines are subjected to acetylation by Spd/Spm acetyltransferase (SSAT) or γ-glutamylation by γ-
glutamylpolyamine synthetases (GPS) (Figure 1.1, Figure 1.2). Human cells take the SSAT route to 
degrade and recycle spermidine and spermine, or pump acetylated products out of the cells. In bacteria, 
the function of SSAT has been reported in E. coli (speG)(31, 68), B. subtilis (bltD)(115), and a specific 
strain lineage of S. aureus(speG) (48).  P. aeruginosa and related bacteria do not seem to have an 
apparent SSAT homologue based on sequence comparison. Instead, our recent report (120) and 
preliminary data demonstrate the presence of a specific GPS, PauA2, that is absolutely required for Spm 
and Spd catabolism. Therefore, Spm modification enzymes are the major defensive players against 
spermine toxicity inside the cell. 
Spermine uptake 
Since most bacteria do not make spermine through de novo synthesis, besides catabolism, homeostasis of 
this polyamine would be also be controlled by uptake. Most bacteria are capable of transporting 
exogenous polyamines into the cells through specific ABC transporters which in general consist of a 
substrate-binding protein (in the periplasm for Gram-negative bacteria), two channel-forming proteins and 
a membrane-associated ATPase that is involved in energy supply(45).  In E. coli, potABCD and potGHIF 
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are demonstrated as spermidine-preferential and putrescine-specific uptake systems, respectively (51). In 
P. aeruginosa, the spuEFGH transporter is essential for Spd and Spm uptake and utilization (70). In 
Gram-positive Streptococcus pneumonia, the extracellular protein PotD encoded within the potABCD 
operon for a putative spermine/putricine transporter also showed capability of binding polyamines (114).  
 
1.4 SPERMINE/POLYAMINE EFFECTS ON β-LACTAMS SUSCEPTIBILITY IN BACTERIA 
Several interesting effects of exogenous polyamines on antibiotics (61, 63) have been reported by our 
group. In particular, spermine was shown to increase the susceptibility of both Gram-negative P. 
aeruginosa and E. coli and Gram-positive MRSA to β-lactam antibiotics.   
 
A number of mechanisms have evolved in bacteria to increase resistance against β-lactams, such as a 
decreased permeability of the outer membrane, export of the antibiotics (these two mechanisms are 
restricted to Gram-negative bacteria), degradation of the antibiotic by β-lactamases or utilization of 
penicillin-binding proteins (PBPs) with low affinities to β-lactams. From the results of a series of studies 
in Gram-negative bacteria, the possibilities of spermine exerting its sensitization effect through β-
lactamases, outer membrane permeability, or efflux pumps(62) have been ruled out. Beyond that, 
alteration of antibiotic target, in this case PBPs may provide another way to mediate β-lactam 
susceptibility.  
 
1.5 PENICILLIN BINDING PROTEINS AND β-LACTAM RESISTANCE 
β-lactam antibiotics, with the β-lactam ring as a shared feature, inactivate the enzymes (PBPs) which are 
involved in the final stage of cell wall synthesis. As the major component of bacterial cell wall, 
peptidoglycan (PG) is made of glycan chains of alternating N-acetylglucosamine (GlcNAc) and N-
acetylmuramic acid (MurNAc) cross-linked by short stem peptides attached to the MurNAc (Figure 1.3A). 
The synthesis of PG occurs mainly through the action of PBPs. PBPs catalyze the polymerization of the 
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glycan strand (transglycosylation) and the cross-linking between glycan chains (transpeptidation). Some 
PBPs can hydrolyze the last D-alanine of stem pentapeptides (DD-carboxypeptidation) or hydrolyze the 
peptide bond connecting two glycan strands (endopeptidation, reverse activity of transpeptidation)(94).  
 
While the primary sequence may be quite different, all PBPsshare a common penicillin-binding domain 
(PB domain) harboring the SXXK motif. The serine residue of the SXXK motif attacks the carbonyl of 
the second-to-last D-Ala of the stem peptide, which releases the last D-Ala from the donor peptide and 
forms a covalent acyl-enzyme complex. In the transpeptidation reaction, the D-Ala carbonyl-Ser ester 
linkage undergoes an attack from a primary amine of the third residue Lys of a second ‘acceptor’ stem 
peptide (in S. aureus through the amine group of penta-Gly attached to Lys of stem peptide). A peptide 
bridge is then created between two stem peptides, forming a link between glycan strands (Figure 1.3B). In 
DD-carboxypeptidation reaction, the acyl-enzyme intermediate is hydrolyzed, thereby preventing the side 
chain from serving as a donor in the formation of a peptide cross-link.  
 
β-Lactams mimic the D-Ala-D-Ala dipeptide and act as inhibitors (Figure 1.3C, D). The active site serine 
attacks the carbonyl of the β-lactam ring, resulting in the opening of the ring and formation of a covalent 
acyl-enzyme complex. This complex is hydrolyzed very slowly, thus effectively preventing further 
reactions (123). 
 
PBPs have been categorized as high molecular mass (HMM) and low molecular mass (LMM) PBPs. 
HMM PBP contains multi modules: a cytoplasmic tail, a transmembrane anchor, an N-terminal domain, a 
β-rich linker and a C-terminal transpeptidase (TPase) domain. Depending on the catalytic activity of the 
N-domain, HMM PBPs belong either to Class A (HMMA)with N-domain as transglycosylase (TGase), or 
class B (HMMB)with N-domain interacting with other proteins and playing roles in cell morphogenesis. 
The LMM PBPs have commonly been found to possess DD-carboxypeptidase activity and/or TPase 
activity (99). 
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In S. aureus, there are four native PBPs (PBP1-3 as HMM PBPs and PBP4 as LMM PBP) and one 
acquired PBP2a (HMM PBP) attributive to MRSA (Table 1.2). PBP1 is a mono-functional transpeptidase 
(HWWB) essential for cell viability and required for cell separation at the end of cell division. It localizes 
to the division septum in a way that is independent of its substrate-bindng ability (79, 80) . PBP2 is an 
essential bi-functional transglycosylase and transpeptidase (HMMA) that plays a central role in the ability 
of bacteria to express their resistance to antibiotics. It localizes to the division septum through a 
mechanism that is dependent on its ability to recognize the substrate (88). PBP3 and PBP4 are non-
essential (85, 116). PBP3 is a mono-functional transpeptidase (HMMB) whose localization and substrate 
reorganization have not yet been studied in detail. PBP4, the single LMM PBP, which has been shown to 
have a low affinity for most β-lactams, is unique among LMM PBPs in that it possesses TPase and DD-
carboxypeptidase activities(37). Like PBP1 and PBP2, PBP4 can be found at the septum of S. aureus. 
Particularly, PBP4 was shown to make high-degree cross-linking in concert with PBP2 and other cell wall 
components (e.g. wall teichoic acid, WTA), and was important for resistance to antibiotics (6).  
 
In addition to the four native PBPs, MRSA strains have acquired another HMMB PBP, PBP2a, encoded 
by mecA situated in the chromosome in a genomic island designated staphylococcal cassette chromosome 
mec (SCCmec). Unlike native PBPs, PBP2a has a remarkably low affinity for all β-lactams, thus enabling 
the protein to continue cell wall synthesis in the presence of these antibiotics(36). PBP2a and PBP2 
function cooperatively in the presence of β-lactam, possibly as a multi-enzyme complex (together with 
other PBPs and other enzymes used for PG synthesis and cell division), to ensure orderly peptidoglycan 
synthesis at the septum with no delocalization of PBP2 (67, 84). 
 
Besides mecA, some additional factors that inactivate β-lactams or interfere with cell wall architecture 
orsynthesis also have the potential to modulate β-lactam resistance: the production of β-lactamase 
encoded by an extrachromosomal gene blaZ (another major resistance mechanism to β-lactams, but not 
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present in all MRSA), the TGase-catalyzed elongation of glycan chains (84), the abnormal configuration 
of stem peptide (9), the imbalance between PG synthesis and autolysis (111), etc. 
 
1.6 RESEARCH OVERVIEW 
My research throughout the Ph.D program is focused on (i) elucidating the mechanisms of resistance and 
stress response against polyamine toxicity in two pathogens, S. aureus and P. aeruginosa; and (ii) 
polyamine utilization pathways in P. aeruginosa. These two seemingly separate subjects unite together in 
the sense that both help us better understand bacterial physiology and ultimately control infections in 
humans. The major content of the dissertation is only concentrated on the S. aureus part, with the P. 
aeruginosa part enclosed in Appendix C as two published articles  (120). 
 
S. aureus is an opportunistic pathogen responsible for hospital- and community-acquired infections 
ranging from localized benign skin infections to life-threatening conditions such as osteomyelitis, 
pneumonia, sepsis and endocarditis. Staphylococcal infections are becoming increasingly difficult to treat 
because of the rapid emergence of MRSA, which have developed resistance to virtually all β-lactam 
antibiotics. They are intrinsically resistant to β-lactams by virtue of newly acquired low-affinity PBP2a, 
with the ability to build the cell wall when other PBPs are blocked by β-lactams. Considering the 
acquisition and horizontal dissemination of resistant genes are evolved with the clinical use of antibiotics 
in excess, instead of developing new drugs, exploring compounds that can restore the efficacy of 
previously ineffective antibiotics may have more potential to combat the evolving resistance.  
 
In this context, we are examining the anti-staphylococcal potential of spermine, a polyamine found in 
abundance in human beings especially at inflammation. At low concentration, spermine has negligible 
intrinsic antibacterial activity but able to sensitize β-lactam antibiotics in a β-lactamase-independent 
manner. At high concentration, spermine per se can inhibit bacterial growth. Therefore in Project I. 
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Exploring the target(s) of spermine-dependent synergy with β-lactams in MRSA, to understand the 
mechanisms involved in the profound changes of β-lactam susceptibility engendered by spermine, 
different strategies were employed: 1) Selection of spermine/β-lactam resistant mutant and identification 
of the responsible mutation site(s); 2) Characterization of spermine effects on cell wall synthesis, via 
genetic and biochemical approaches; 3) Depiction of spermine/β-lactam mediated transcriptomic 
alterations through microarray analysis. Studies on those aspects will be described in Chapter 2  (121) , 
Chapter 3, and Chapter 4, accordingly. In Project II. Elucidation of S. aureus responses to spermine 
toxicity, to reveal new information regarding the stress response to Spm, the transcriptome analysis on 
MRSA Mu50 was conducted upon exposure to high dose Spm by time course, and some candidate genes 
with significant levels of induction were subjected to further characterization through genetic and 
biochemical experiments. Studies on this project are reported in Chapter 5. 
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Figure 1. 3 PG synthesis and β-lactam antibiotics. 
A. Schematic representation of basic structure and synthesis of cell wall in S. aureus. 
B. Catalysis of transpeptidation during PG synthesis. Fragments of glycan strands are represented by 
chains of hexagones standing for GlcNAc(G) and MurNAc(M). The ‘donor’ stem peptide is depicted on 
the upper glycan strand, whereas the ‘acceptor’ is attached on the lower strand. The composition of stem 
peptide may differ in various species. Note that in S. aureus, penta-Gly is attached to the third residue of 
the acceptor peptide, and provide the free amine that attacks the acyl-enzyme intermediate.  
C, D. Structural similarity between the natural substrate of the PBPs and β-lactams. (C) N-Acyl-D-
Alanyl-D-Alanine peptide. (D) Penicillin backbone. The regions of negative electrostatic potential are 
indicated by arcs. B-D, adapted from Andr´e Zapun, et al. (2008) FEMS Microbiol Rev  
 
Table 1. 2 PBPs in MRSA 
 
 *HMMA, high molecular mass class A; HMMB, high molecular mass class B; LMM, low molecular mass  
B
C
TPase
TGase
Muramidase
Amidase
MurABCDEFG
MraY, FemXAB
N-Acetylmuramic acid
N-Acetylglucosamine
L-Alanine
D-Glutamate
L-Lysine
D-Alanine
Penta-Glycine
A
D
PBP class* Function in vivo Essentiality in S.aurues
PBP1 HMMB transpeptidase essential
PBP2 HMMA transglycosylase, transpeptidase essential
PBP3 HMMB transpeptidase non-essential
PBP4 LMM carboxypeptidase, transpeptidase non-essential
PBP2a HMMB transpeptidase non-essential
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CHAPTER 2: A PBP2 MUTANT DEVOID OF THE TRANSPEPTIDASE DOMAIN ABOLISHES 
SPERMINE / β-LACTAM SYNERGY IN STAPHYLOCOCCUS AUREUS MU50 
2.1 INTRODUCTION 
β-Lactam antibiotics function by irreversibly occupying the serine residue at the active site of penicillin 
binding proteins (PBPs), and formation of this stable ester-linked acyl enzyme inhibits the 
transpeptidation step during cell wall cross-linking (32). In S. aureus, there are four native PBPs (PBP1-4) 
and one acquired PBP2a attributive to MRSA. In contrast to other PBPs, PBP2a encoded by the mecA 
gene shows low affinity to β-lactams due to inefficient formation of the acyl-PBP intermediate, and thus 
ensures continued cell wall synthesis when normal PBPs are inactivated by β-lactams (36). Besides mecA, 
additional factors affecting cell wall architecture or synthesis are believed to have the potential to perturb 
or modulate β-lactam resistance in S. aureus, such as glycan chain length (87), stem peptide configuration 
(25), pentaglycine cross-bridge (10), coordinated activity of peptidoglycan (PG) biosynthesis and 
autolysis (5), etc. Particularly, one of the native PBPs, PBP2, is essential for the high level of methicillin 
resistance in MRSA. PBP2 belongs to the high-molecular-weight class-A PBPs with a transglycosylase 
(TG) domain and a transpeptidase (TP) domain. When exposed to β-lactams, PG synthesis in MRSA can 
be achieved at the division septum mediated by the cooperative functioning of the TG domain of PBP2 
and the TP domain of PBP2A, possibly as part of a multi-enzyme complex in cell wall synthesis (87, 88).  
 
In the current study, we isolated a MRSA strain derivative (MuM) conferring spermine resistance by 
serial passages in vitro, and compared its genetic basis as well as the phenotypic profiles with those of its 
parental strain Mu50. We found that this mutant not only possesses 32-fold increase in tolerance of 
growth inhibition by spermine, it also loses completely the spermine/β-lactam synergy. Furthermore, a 7-
bp deletion within the pbpB gene which encodes the essential PBP2 was revealed by genome 
resequencing, through which the transpeptidase activity was deprived. Complementation of plasmid-
borne wild-type pbpB to the mutant can restore its sensitivity to both spermine and the synergy. In 
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addition, the reduced tolerance of cell wall to hydrolysis and decreased autolytic activity were observed in 
this mutant, which may be due to changes on cell wall metabolism as a result of this pbpB lesion. This 
mutation also posted a pleiotropic effect on gene expression as revealed by transcriptome analysis. Taken 
together, our results lend support to the idea that exogenous spermine may affect cell wall synthesis 
through its interactions with PBP2 and/or PBP2-assoicated multi-enzyme machineries to enhance the 
killing effect of β-lactam antibiotics. 
 
2.2 MATERIALS AND METHODS 
Bacterial strains, plasmids, and growth conditions   
S. aureus Mu50 (ATCC700699), COL (obtained from NARSA), RN4220 (kindly provided by R. P. 
Novick) and E. coli DH5α (Bethesda Research Laboratories) were employed in this study. Plasmid 
pCN38 (ampicillin and chloramphenicol resistance), a shuttle vector of E. coli and S. aureus (16), was 
used for gene cloning. Both E. coli and S. aureus strains were routinely grown and maintained in the 
Luria-Bertani (LB) medium. When required, the LB medium was buffered with 20mM Tris-HCl of 
indicated pH. Antibiotics were added to the media as necessary at the following concentrations: 
ampicillin, 100μg/ml (for E. coli); chloramphenicol, 10μg/ml (for S. aureus). 
Isolation of spermine-resistant mutants  
Spontaneous mutants of the MRSA Mu50 (oxacillin MIC of 512 μg/ml and spermine MIC of 1 mM at 
pH8.0) were isolated by spreading 1×108 CFU of log-phase cells onto spermine-containing plates (2-8 
mM, pH8.0) and incubated overnight at 37 ºC. One independent colony recovered from plates with 8 mM 
spermine, and it remained resistant to spermine (up to 32 mM) in broth and on plates. This mutant strain 
was designated as MuM in this study. 
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Genotypic characterization of spermine-resistant mutant MuM  
The chromosomal mutation in MuM was identified by pyrosequencing carried out using the 454 Life 
Sciences Technology at the University of Florida. Genomic DNA from both Mu50 and MuM were sent 
for sequencing, assembled, and compared to the published genomic sequence of S. aureus Mu50 
(GeneBank Accession BA000017.4). The mutation unique to MuM identified in the pbpB gene was 
confirmed by PCR amplification and DNA sequencing by the following two primers: 5’-
GGTTTAGTTGCTATATCTGGTGG-3’ and 5’-CGCGTTGTTATAAGTACCACCG-3’.  
Spermine and antibiotic susceptibility tests 
Minimal inhibition concentrations (MICs) of antibiotics or spermine were determined by a liquid micro-
dilution method according to the guidelines of the Clinical and Laboratory Standards Institute(18). Serial 
two-fold dilutions of tested compounds were prepared in a 96-well microtiter tray, and fresh overnight 
cultures of each bacterial strain were diluted and inoculated with approximate 105 CFU/well. Cells were 
incubated without shaking at 37 ºC for 24h (or up to 36h as specified). The lowest concentration of 
antimicrobial agent at which cells were not able to grow was defined as its MIC. 
Transcriptome analysis 
Mu50 and MuM were grown in Tris-buffered LB (pH7.5), and cultures in the exponential phase (OD600 
around 1.0) were immediately treated with the RNAprotect Bacteria ReagentRNA protection reagent 
(QIAGEN) before harvesting. RNA samples were extracted from cells by phenol (Fisher), digested by 
RNase-free DNase I (Roche) to remove genomic DNA, and purified with RNeasy mini columns 
(QIAGEN). cDNA synthesis, fragmentation and terminal labeling were carried out according to the 
protocols by the manufacturer (Affymetrix). Labeled cDNA was hybridized to GeneChip S. aureus 
Genome Array. After scanning, the images were processed with GCOS 1.4 software (Affymetrix). Data 
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consisting of three independent biological experiments were analyzed by comparing gene expression of 
MuM to Mu50 with fold change over 2.5, and signal intensity value 200 as threshold.  
Complementation of pbpB 
The pbpB gene was reported to transcribe independently or as a polycistronic RNA from its upstream prfA 
promoter (86). To ensure optimal expression, a 3.2-kb fragment covering both  prfA and pbpB was 
amplified by PCR from the Mu50 genomic DNA with the following two primers:5’- CGCGGATCCACA 
CATACTTGTACTTGCCTC-3’ and reverse primer 5’-
CGCGGCGCCGAGTGGATTAGTTGAATATACCTGTTAATCCACCGCTG-3’. The resulting PCR 
product was cloned into BamHI and NarI sites of the shuttle vector pCN38. The recombinant plasmid 
pYX9 was first cloned into and extracted from E. coli and then electroporated into S. aureus RN4220 by 
GenePulser Xcell (Bio-Rad) with parameters as described previously (60). Plasmid DNA isolated from 
recombinant strains of RN4220 was subsequently introduced into Mu50 and MuM by electroporation. 
PBPs profiling  
Membrane fractions were prepared as described previously (75) for detection of PBPs. Protein samples 
(50μg) were incubated with 5μM Bocillin FL (Invitrogen) for 30min followed by SDS-PAGE on a 10% 
gel. The fluorescent Bocillin covalently bound to the PBPs were detected with excitation at 488nm and 
emission at 520nm (Typhoon 9400). Due to its low affinity to Bocillin, PBP2a was detected by 
immunoblots with mouse anti-PBP2a antibodies (Abnova; 1: 5000 dilution), followed by rabbit anti-
mouse IgG antibodies conjugated with alkaline phosphatase (Sigma; 1:30,000 dilution) and chromogenic 
substrates. 
Triton X-100-induced autolysis assays 
This assay was conducted by following a protocol as described previously (22) with minor modifications. 
Briefly, cells were harvested, washed twice with ice-cold water, and then re-suspended in the same 
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volume of 50mM Tris-HCl (pH 7.2) containing 0.05% Triton X-100. Cells were incubated at 30°C with 
shaking (~250rpm) and checked for lysis by measuring the progressive decrease in absorbance (OD600). 
Autolysis was quantified as a percentage of the initial OD600 remaining at each sampling point. 
Preparation of autolytic enzyme extracts  
Cellular extracts enriched with autolytic enzymes were prepared as previously described (56) with some 
modifications. Briefly, the cells were grown to mid-exponential phase in 20ml of LB (20mM Tris-Cl, 
pH7.5) at 37°C with aeration to OD600 of 1,  chilled on ice, harvested by centrifugation, and washed twice 
with ice-cold 50 mM Tris-HCl (pH 7.5) buffer with 150 mM NaCl. The pellet was directly suspended in 
80 µl of 4% SDS for 30min at room temperature or 400 µl of a solution containing 3 M LiCl and 0.1% 
TX-100 for 30 min at 4°C with stirring. After centrifugation at 10,000 x g for 10min, the supernatants 
were collected as SDS extracts or LiCl extracts, which were used in zymographic analysis or in vitro 
enzymatic hydrolysis of crude cell walls, respectively.  
Enzymatic hydrolysis of crude cell walls in vitro  
This assay was performed as previously described (5). Briefly, crude cell walls were prepared from cells 
(10ml) grown to mid-exponential phase (OD600 around 1). Cell pellets were boiled in 8% SDS for 30min 
and washed three times with hot water to remove SDS. The obtained pellets as crude cell walls were 
suspended in 50 mM Tris-HCl (pH 7.5) to an OD600 of 0.6, and LiCl extracts as described above were 
added to start hydrolysis. The reaction was conducted at 37°C with  shaking (~250rpm), and  the 
hydrolysis rate was measured as a decrease of OD600. 
Zymographic analysis 
Heat-killed cells of S. aureus RN4220 were prepared as the substrate for hydrolytic enzymes. Briefly, the 
cells in mid-exponential phase were harvested, and the pellet was suspended in 2× Laemmli SDS sample 
buffer and heated for 5 min at 100°C. The heat-inactivated cells (with OD600 equivalent to 10) in 1/10 
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volume of the resolving-gel (10%) solution was added to cast the gel, and the SDS-extracts as described 
above were applied to such SDS-PAGE to detect the hydrolytic activities. After electrophoresis, the gel 
was soaked for 30 min in distilled water at room temperature, then transferred into the renaturing buffer 
(25 mM Tris-HCl, 1% [vol/vol] Triton X-100, pH 8.0) with gentle shaking for 16 h at 37°C to allow for 
renaturation. The renatured autolysins appear as clear translucent bands on the opaque background, and 
the contrast can be enhanced for photography by staining the gels in 1% (wt/vol) methylene blue with 
0.05% KOH. 
Preparation and analysis of extracellular protein fraction 
For the preparation of extracellular protein extracts, bacteria were grown in LB medium to exponential 
phase. After centrifugation, extracellular proteins in the supernatant (2 ml) were precipitated by 0.02% 
sodium deoxycholate at 4°C for 30min followed by 10% (w/v) trichloroacetic acid at -20°C overnight. 
The precipitates were harvested by centrifugation at 4°C, 16,000 x g for 20min, washed with 100% ice-
cold acetone twice and dried. The protein pellet were resolved in an appropriate volume of Laemmli SDS 
sample buffer, boiled and separated on 10% SDS-PAGE. Bands showing different intensities between 
MuM and Mu50 samples were identified by MALDI-TOF MS/MS. 
Electrospray ionization mass spectrometry (ESI-MS) 
Solutions of spermine and oxacillin (2mM), either alone or in combination, were prepared in the 
ammonium acetate buffer (5mM), and the final pH was adjusted by formic acid or ammonium hydroxide. 
All solutions were directly injected for ESI-MS analysis. Mass spectral acquisition was done in the 
positive ion mode using the following parameters: capillary voltage 3000V, sample cone voltage 35, 
extraction cone voltage 2.5, source temperature 120 oC, desolvation temperature 150 oC, gas flows 
desolvation 500 l/h, pump flow rate 5 µl/min. 
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2.3 RESULTS 
Growth inhibition of Mu50 by spermine is pH-dependent 
While spermine and β-lactams exert a strong synergy effect on MRSA (61), spermine per se can cause 
growth inhibition on all tested strains of S. aureus (Mu50, N315, COL, RN4220 with MICs of 1mM, 
1mM, 0.5mM, and 2mM, respectively, at pH 8.0). To further understand the adverse effect of spermine, 
we first tested whether this effect is growth phase-dependent. As shown in Figure. 2.1, growth of Mu50 in 
the buffered LB broth (20mM Tris-Cl, pH 8.0) was immediately inhibited by the addition of spermine 
(10X MIC; 10mM) regardless of the growth stage.  
 
Spermine is a tetra-amine, and its four pKa values were reported as 10.80, 10.02, 8.85, and 7.96 (11). At 
pH 7.4, the relative abundance of +4/+3 species was 3/1, and the ratio could be 1/1 at pH 8.0. If not 
protonated, the amino group would serve as nucleophile for potential chemical reactions. To analyze the 
possible effect of spermine net charge on growth inhibition, spermine MIC was determined in Mu50 
suspended in buffered growth media of different pH values as shown in Figure. 2.2 A. When pH is at 7.0 
or lower, fully positive-charged spermine did not post a strong inhibitory effect on growth as reflected by 
MICs of 32-64 mM. Interestingly, MIC was reduced to 2 mM at pH 7.5, and was decreased further to 
0.125 mM at pH 9.0 or higher. Since the net positive charge of spermine is reduced when the pH value is 
increased, these results strongly suggest that the growth inhibition effect of exogenous spermine may not 
be related to its positive charges, and instead its nucleophilic property may be the cause. 
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Table 2. 1 MICs of oxacillin, vancomycin, and spermine in Mu50 and MuM. 
Antibiotic 
reagent 
MIC* for 
Mu50 
 
MuM 
 
Mu50/pYX9 
 
MuM/pYX9 
        
- 0.5mM Spm - 
0.5mM 
Spm - 
0.5mM 
Spm - 
0.5mM 
Spm 
Oxacillin 
(µg/ml) 512 <1 
 
1024 1024 
 
512 <1 
 
1024 <1 
Vancomycin 
(µg/ml) 4 4 2 <0.03 8 4 8 4 
Spermine 
(mM) 2 64 2 2 
   
* MICs were determined in LB broth with pH adjusted to 7.5.  
   Plasmid pYX9 carries the wild-type pbpB gene 
 
 
 
 
Figure 2. 1 Growth inhibition by exogenous spermine. 
Cells from a fresh overnight seed culture were inoculated into pre-warmed LB broth (pH8.0). Spermine 
(Spm; 10mM) was added at indicated time points after inoculation, and OD600 was monitored at every 1-
hr intervals. 
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Effects of pH on oxacillin/spermine synergy of Mu50 
Meanwhile, we also analyzed the pH effect on oxacillin / spermine synergy by measuring oxacillin MIC 
in the presence of spermine at different pH (1/4 of MIC for pH 7.5 to 9.5; 0.5mM for pH 6 to 7). Like 
spermine per se, such synergy also followed the same trend of pH dependence (Figure 2.2B), but only 
when pH was equal to or lower than 8.0. Unexpectedly, at pH 8.5 and higher, oxacillin MIC took a 
reversed trend and increased 16-fold from that of pH 8.0, and a further 32-fold increment was observed if 
recorded after 24 more hours of incubation. These results led us to propose oxacillin inactivation by a 
possible chemical reaction between nucleophilic spermine and the β-lactam ring of oxacillin (77). 
 
To test this hypothesis, possible formation of spermine-oxacillin conjugates was analyzed by ESI-MS in 
the positive-ionization mode as shown in Figure 2.3. In comparison to the mass spectra for spermine and 
oxacillin (2mM), a new peak corresponding to the proposed spermine-oxacillin conjugate (m/z 604.5) 
appeared in the mass spectrum of an equamolar mixture (2mM) of spermine and oxacillin at pH 9.0, but 
not in that of a mixture at pH 7.0. These data support pH-dependent formation of chemical conjugates 
between spermine and β-lactams, and were consistent with patterns of MIC readings in Figure 2.2. 
Selection and preliminary characterization of a spermine-resistant mutant MuM 
Strain MuM, a spermine-resistant mutant of Mu50, was isolated through selection on high concentrations 
of spermine as described in Materials and Methods. MuM exhibited resistance to spermine, with an MIC 
32-fold higher than that of the parental Mu50 (Table 2.1). The genetic modification(s) in MuM was 
specific for spermine as MICs of several tested antibiotics (streptomycin, tetracycline, gentamicin, 
erythromycin, chloramphenicol, kanamycin, spectinomycin) on MuM were the same as those of Mu50. 
However, we observed significant changes on the growth behavior of MuM. In comparison, colonies of 
MuM on LB plates were homogeneously smaller than those of the parent strain, and these colonies 
required over 18h to recover from the lag phase at 37°C when inoculated into the LB broth.  Once in the 
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logarithmic phase, the doubling time of MuM was over 3.5-fold longer than that of Mu50 (127 min v.s. 
35 min; Figure 2.4A). However, fast-growers started to appear after continuous passage of MuM on LB 
plates, suggesting the rise of compensatory mutations from growth impairment (4). To maintain a stable 
MuM, we found that glucose supplement in the LB medium was indeed helpful as evidenced by a reduced 
doubling time to 70 min with a shortened lag phase (Figure 2.4A), and the spermine-resistance phenotype 
as well as homogeneous colony size remained after passages. Another interesting phenotype of MuM was 
that this strain is a temperature-sensitive mutant; no apparent growth can be detected at 42oC. 
Growth limitation of MuM by pH 
To examine the pH dependence of spermine effects in MuM, MIC measurements of spermine were 
conducted under different pH conditions. Contrary to the pH-dependent trend in its parental strain Mu50 
(Figure 2.2A), spermine MIC in MuM was estimated to be 64 mM at pH 6.0-8.0, but surprisingly was 
dropped to an undetectable level at pH 8.5 or higher. This prompted us to monitor the growth of MuM 
and Mu50 in the buffered LB broth of pH 6.0-9.5 in the absence of exogenous spermine.  Strain Mu50 
grew comparably at pH 6.0-8.5, and the growth rate was significantly reduced at pH 9 and 9.5 (Figure 
2.4C). In comparison, MuM exhibited its optimal growth at pH 7.5-8.0 and basically showed no growth at 
pH 9.0 and higher (Figure 2.4B).  
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Figure 2. 2 pH-dependent effects of spermine or spermine/β-lactam synergy. 
(A)MIC of spermine per se (B) MIC of oxacillin in the presence of spermine. 
MICs of spermine or oxacillin were determined at different pH in Mu50. For measurements of oxacillin 
MICs, 0.25-fold MIC (for pH 8.0-9.5) or 0.5mM (for pH 6.0-7.5) of spermine was included.   
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Figure 2. 3 ESI mass spectrum analysis. 
All compounds were dissolved in ammonium acetate buffer (5mM), and mass spectra were acquired in 
positive ionization mode. (A) spermine; (B) oxacillin; (C) equal-molar mixture of spermine and oxacillin 
at pH 7; (D) equal-molar mixture of spermine and oxacillin at pH 9. 
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Figure 2. 4 Growth behaviors of Mu50 and MuM. 
Growth of the cells in LB broth at 37°C with aeration was monitored by OD measurements. (A) Growth 
in the presence or absence of 0.4% glucose; (B) Growth of MuM in LB buffered with 20 mM Tris-HCl of 
indicated pH; (C) Growth of Mu50 in LB buffered with 20 mM Tris-HCl of indicated pH. 
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Loss of spermine/β-lactam and gain of spermine/vancomycin synergy in MuM 
MICs of oxacillin and several different types of antibiotics in the presence and absence of spermine were 
determined in MuM and its parental stain Mu50. The results indicated that while spermine posted its 
synergy effect exclusively on β-lactams in Mu50, MuM behaved differently from Mu50 only on oxacillin 
(β-lactams in general) and vancomycin. As shown in Table 2.1, MICs of oxacillin in the absence of 
exogenous spermine were comparable in MuM and Mu50. In the presence of 0.5 mM spermine, over 500-
fold reduction of MIC to oxacillin was observed in Mu50, whereas this sensitization effect was 
completely compromised in MuM. In the case of vancomycin, while its MIC was not affected by the 
presence of spermine in Mu50, MuM exhibited a considerable increase of susceptibility to this antibiotic 
when spermine (0.5 mM) was supplemented (Table 2.1). As a inhibitor of cell wall synthesis, vancomycin 
works by binding to the D-Ala-D-Ala moiety, and subsequently blocking cross-linkage, of the murein 
monomers during the transpeptidation reactions by PBPs (92). Such opposite responses of MuM to β-
lactam and vancomycin in the presence of spermine raised the possibility that spermine may directly or 
indirectly inhibit cell wall synthesis.  
Genome resequencing of MuM and Mu50 identified a genetic defect in pbpB 
To identify the mutation(s) responsible for spermine resistance, genome resequencing of MuM and Mu50 
was conducted by the 454 Sequencer FLX System. On average, total base-pair reads exceeded over six 
times of the genome size, and the generated contigs covered more than 98% of the published genome 
sequence of Mu50. Through sequence comparison, only one sequence variation was identified between 
Mu50 and MuM: a 7-bp deletion in MuM which was located at nt 1366-1372 within the pbpB gene 
encoding an essential penicillin binding protein (PBP) in S. aureus, PBP2 (Figure 2.5A). The presence of 
this deletion in MuM was confirmed by sequencing of a 461-bp fragment covering this region by PCR 
amplification from the genomic DNA of Mu50 and MuM.   
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The PBP2 protein is composed of 727 amino acids (Mr of 80,236) with an N-terminal transglycosidase 
domain spanning residues 82-258, and a C-terminal transpeptidase domain spanning residues 361-629 
(Figure 2.5A; UniProtKB/TrEMBL:Q99U39). All PBPs share a common penicillin-binding (PB) domain 
which binds β-lactam antibiotics due to the structural similarity between β-lactams and the D-Ala-D-Ala 
moiety of the nascent peptidoglycan, the natural substrate of PBPs. The PB domain is composed of two 
subdomains, and three motifs broadly conserved in PBPs lie at the interface of these two subdomains. In 
the case of S. aureus PBP2, these three motifs comprise SSLK401, SFN456, and KTG585, with S398 being the 
primary active residue (98). In MuM, a frame-shift by the 7-bp deletion in pbpB incurs an immediate stop 
codon that truncates the translated product from N456, right at the 2nd consensus motif, and deprives the 
C-terminal transpeptidase domain of PBP2 (Figure 2.5A). As a result, the mutated PBP2 was expected to 
lose its formation of an acyl linkage with β-lactams. To test this hypothesis, we conducted PBP labeling 
with Bocillin, a fluorescent derivative of penicillin. As shown in Figure 2.5B, PBP2 was not detectable in 
the membrane preparation of MuM, supporting the presence of a truncated PBP2 in this mutant. 
Complementation of the spermine-resistant MuM by pbpB 
Plasmid pYX9 carrying pbpB of Mu50 was constructed for complementation tests. As shown in Table 2.1, 
MuM carrying pYX9 restores spermine sensitivity and the synergy effect of spermine and β-lactams. 
Plasmid pYX9 also restores the tolerance of MuM to vancomycin to the wild-type level in the presence of 
spermine. Meanwhile, empty vector (pCN38) does not rescue those phenotypes in MuM (data not shown). 
For growth kinetics, MuM/pYX9 grows much faster than MuM, with an estimated generation time 
comparable to that of Mu50 (data not shown). In addition, the pH sensitivity of growth was diminished in 
MuM/pYX9, indicating a correct form of PBP2 is required for the buildup of a rigid and strong cell wall 
to resist diverse environmental challenges.  
 
It was suggested that different PBPs may work in concert or form a complex to coordinate the PG 
synthesis (66). In order to see whether the sophisticated regulation of different PBPs can be affected by 
28 
  
the addition of PBP2, PBPs profiles were compared in Mu50 and MuM with or without pYX9. As shown 
in Figure 2.5B, introduction of plasmid-borne wild-type PBP2 did not have apparent effects on the 
production of other PBPs. MuM with empty vector (MuM/pCN38) shows same PBPs patterns as 
observed in MuM (data not shown). Moreover, a similar level of PBP2a was detected in MuM and Mu50 
by immunoblots (Figure 2.5B), suggesting that the genetic lesion of pbpB did not affect mecA expression 
in MuM. As described below, we also conducted transcriptome analysis in MuM and Mu50; consistent to 
the results of Bocillin labeling and PBP2a immunoblots, we found comparable levels of expression for all 
genes encoding penicillin-binding proteins in these two strains (Table S2). 
Effects of the truncated PBP2 in MuM on cell wall hydrolysis 
The mutated pbpB gene of MuM may result in perturbation of cell wall synthesis and change the PG 
structure. To test this hypothesis, sensitivity of MuM and Mu50 cell walls to hydrolytic enzymes was 
analyzed by incubation with a common source of autolytic enzyme extracts from strain COL. Degradation 
of the MuM cell wall materials was significantly faster than the control of Mu50 (Figure 2.6A), 
suggesting cell walls of MuM may be less cross-linked and/or more susceptible to hydrolysis due to the 
defects on PBP2. 
 
It has been reported that enzymes for cell wall synthesis and hydrolysis may be co-regulated, and that the 
decreased expression of pbpB could repress the autolytic system in S. aureus (5). Here a similar situation 
may occur in the case of MuM. Whole-cell autolysis was assessed following exposure of MuM and Mu50 
cells to Triton X-100. As shown in Figure 2.6B, the rate of Mu50 autolysis was significantly faster than 
that of MuM. Since the cell wall of MuM was more susceptible for degradation than that of Mu50 (Figure 
2.6A), the slower rate of autolysis in MuM may be related to a decreased activity and /or quantity of 
autolytic enzymes, in addition to possible alterations on cell wall composition. 
We also conducted zymographic analysis of autolytic enzymes from Mu50 and MuM. Taking crude cell 
walls of RN4220 as substrate, a couple of bacteriolytic bands of cell wall hydrolysis by the enzyme 
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extract from MuM were less intense than those from Mu50 (Figure 2.6C). Although the exact identify of 
these affected hydrolytic enzymes cannot be determined from this experiment, they may include the 
autolysin ATL of 138 kDa and its proteolytic products of 62 and 51 kDa (57). In addition, the secreted 
protein profiles from the spent medium of MuM and Mu50 in the logarithmic phase of growth were 
compared following SDS-PAGE. As shown in Figure 2.6D, one polypeptide appeared preferentially in 
the protein sample of Mu50 but was completely absent in that of MuM, and this peptide was identified as 
autolysin ATL by MALDI-MS-MS.  
 
While the results of Figure 2.6C suggest a reduced activity of cell wall hydrolytic enzymes in MuM, 
surprisingly transcriptome analysis (Table S2) reveals no apparent difference in MuM and Mu50 on 
expression of the major hydrolytic enzymes encoded by atl, sle, lytM, and SA0620/SAV0665 (5). Since 
autolysin ATL requires proteolytic processing to reach its maximal activity, these somewhat contradictory 
results may be explained by a decreased level of ATL proteolytic processing and a greater degree of ATL 
retention within the cell wall of MuM, perhaps as the consequence of possible alterations on the PG 
composition due to the pbpB lesion. 
Transcriptome analysis 
Multiple phenotypic changes of MuM prompted us to evaluate the transcriptional profiling imposed by 
the defective PBP2. The logarithmic-phase cells of MuM and Mu50 grown in LB alone without spermine 
supplement were subjected to transcriptome analysis as described in Materials and Methods. A total of 
250 genes showing up-regulation and 7 genes showing down-regulation in MuM were identified and 
listed in Table S2. In order to see whether the unique pattern of gene expression in MuM was due to the 
pbpB lesion, we also conducted transcriptome analysis of Mu50 and MuM carrying wild-type pbpB in 
trans. When sorted against MuM/pYX9 and Mu50/pYX9 expression profiles, majority of the changes 
observed in MuM were greatly attenuated in MuM/pYX9, suggesting that the truncated PBP2 is 
responsible for the complicated transcriptional adaptations in MuM. Nonetheless, it is worth noting that 
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there are 10 genes (including czrAB, vraDE, gntPK, oppF, mtlF, SAV0069, SAV0190) showing up- or 
down-regulation in MuM regardless of complementation by pYX9, and the fold change of these genes in 
MuM/pYX9 was even greater than that in MuM. 
 
While one might expect that the pbpB lesion of MuM could affect cell wall synthesis and trigger a 
specific stress response, the gene list in Table S2 shows no overlap with the reported signature genes of 
the cell wall stress stimulon (58, 109). Instead, one intriguing observation was the up-regulation of 67 
genes associated with amino acid biosynthesis and transport that are members of the CodY regulon (71, 
91). In S. aureus, like in many low G+C Gram-positive bacteria, CodY is a central regulator mediating 
amino acid biosynthesis, nitrogen utilization and transport of macromolecules. 
 
Surprisingly, 67 genes residing in several genomic islands (GIs) were found activated in MuM (Table S2), 
and this list could be expanded further if a less stringent factor of fold-change was applied in data analysis. 
These GIs include SCCmec, IS1181-1, SaPIm2, SaGlm, фMu50B, SaPIm3, and фMu50A (59). Although 
little was known about the nature of GI activation, similar activation of GI was observed in a murF 
conditional mutant (103), in which the cell wall synthesis was perturbed in muropeptide maturation.  
Other than the CodY regulon and GIs, genes that were differentially up-regulated in MuM were clustered 
into potential operons – ureABCEFGD for urease synthesis, sbnABCDRFGHI for iron metabolism, 
kdpABCDE for an inducible potassium uptake system, and SAV2094-thiDME for vitamin B2 and 
bioFABD for vitamin H biosynthesis. Specifically, degradation of urea by urease in S. aureus was thought 
to neutralize acidic microenvironments by generating NH3 and CO2 under acid stress (13). In addition, 
MuM also hosts the induced arcABCD operon for the arginine deiminase pathway, a major role of which 
is to alkalinize the medium by generating NH3 and CO2 as well as to energize the cells by production of 
ATP (104, 125). All together, it strongly suggests that MuM is primed to adjust its metabolic activities to 
increase the internal pH, which would imply that the defective cell wall may alter the membrane potential 
and somehow exert a mild acid stress on MuM.  
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Figure 2. 5 Identification of the pbpB lesion in spermine-resistant mutant MuM. 
 (A) Sequence alignment of the pbpB gene from Mu50 and MuM at the mutation site. Also shown were 
the location of the 7-bp deletion (nt 1366-1372) in the pbpB gene of 2184 bp, the amino acid sequence of 
the truncated PBP2 of MuM, and the sizes and locations of the transglycosidase and transpeptidase 
domains of PBP2. (B) Absence of PBP2 in MuM and the presence of other penicillin-binding proteins 
were revealed by Bocillin labeling (top panel) or immunoblot (bottom panel). 
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Figure 2. 6 Analysis of cell wall hydrolysis. 
(A) In vitro susceptibility of cell walls. Crude cell walls of Mu50 (open triangle) and MuM (closed 
square) were subjected to degradation by autolytic enzymes from S. aureus COL. Preparations of these 
samples were described in Materials and Methods. The experiments were reproduced several times, and 
data from a one single experiment were shown here as representatives.  
(B) Triton X-100 induced autolysis of Mu50 (open triangle) and MuM (closed square) cells. Values 
indicate the average of two independent experiments.  
(C) Zymographic analysis of the autolysins in SDS cell extracts from Mu50 (left) and MuM (right). 
Samples were analyzed in a 10% resolving gel containing heat-killed RN4220 cells. Lytic activity was 
detected by incubation of the gel with gentle agitation at 37°C in renaturing buffer. Equivalent amounts of 
protein samples were loaded.  
(D) Protein profiles in culture supernatants. Extracellular proteins from Mu50 (left) and MuM (right) 
were prepared as described in Materials and Methods. The gel was stained with Coomassie Blue to detect 
the total secreted protein profile, and the protein band of autolysin was identified by MALDI-TOF 
MS/MS. 
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2.4 DISCUSSION 
Unique phenotypic behaviors and transcriptional adaptations of MuM 
A spontaneous suppressor mutant of MRSA Mu50 conferring resistance to β-lactams in the presence of 
spermine was isolated through spermine selection. This mutant possesses a unique pbpB lesion, in which 
a 7-bp deletion generates a truncated PBP2 without the C-terminal transpeptidase (TP) domain while the 
transglycosidase (TG) domain at the N-terminus remains intact. Although this pbpB mutant MuM still 
confers β-lactam resistance, its physiological properties are very different from those of the parental strain 
Mu50, a clinical isolate of MRSA in several aspects – gain of spermine resistance, loss of spermine/ β-
lactam synergy, gain of spermine/vancomycin synergy, a slower growth rate, temperature-sensitive 
growth phenotype, a narrow pH range for growth, changes of cell wall composition and turn-over, and a 
lower level of cell wall hydrolase activity. Furthermore, transcriptome analysis reveals a distinct pattern 
of gene expression, showing no overlap with that of the cell wall stress stimulon (58, 109) 
Physiological functions of PBP2 
Our results indicate that the TP domain of PBP2 is not essential for growth and β-lactam resistance of 
MRSA. These conclusions are consistent with a previous report (83) that a Ser398Gly mutation at the TP 
domain leads no effect on MIC to methicillin, but loss of the TG activity by a Glu114Gln mutation causes 
a more than 100-fold decrease on methicillin MIC. On the contrary, the TP activity of PBP2 is essential 
for the growth of MSSA (89), and specific mutations at the TP domain (Pro458Leu) can make MSSA 
resistant to β-lactam antibiotics (67). This discrepancy is due to the presence of a β-lactam insensitive 
PBP2a encoded by the mecA gene of MRSA. The TP activity of PBP2a is able to sustain cell growth 
when that of PBP2 is not available. Investigations from that study provide direct evidence that a mutated 
PBP2 without the TP activity results in altered cell wall composition with reduced amounts of highly 
cross-linked oligomers. This is consistent with the increased cell wall degradation rate of MuM observed 
in our study. 
34 
  
 
In addition to the intrinsic TP and TG activities, PBP2 may serve as scaffold for a multi-enzyme complex 
in cell wall synthesis. The presence of multi-enzyme complex in cell wall synthesis was first proposed 
from studies in E. coli (39, 40). Later, Tomasz and coworkers (67, 83) reported evidence to support that 
PBP2 forms a complex with PBP2a, PBP4, and perhaps other enzymes to coordinate cell wall synthesis 
and hydrolysis. Along this line, one hypothesis was that the TG and TP activities of PBP2 are subjected to 
allosteric regulation within the complex, and the conformation of this complex could be affected by 
changes on the supporting scaffold of PBP2. Built upon this model, we propose a working hypothesis for 
spermine effects on cell wall synthesis in S. aureus as described below. This model may also provide an 
explanation of a somewhat contradictory report that insertion of a transposon at the 3’ end of pbpB (i.e. 
intact TG domain and truncated TP domain) made the affected MRSA susceptible to β-lactams (90).  
The proposed model of spermine/β-lactam synergy in S. aureus 
Spermine was reported to exert a strong synergy effect with β-lactams on MRSA (61). In the current 
study, we present evidence that spermine per se also posts a pH-dependent antibacterial activity against 
strains of S. aureus (MRSA and MSSA), and this activity is most likely mediated by the nucleophilic 
property instead of positive charges of spermine.  In search of the potential target of spermine by the 
genetic approach, the observed spermine-related phenotypes of MuM led us to propose that PBP2 itself or 
enzymatic activities associated with the PBP2-dependent complex in cell wall synthesis could be good 
candidates.  
 
The working model we envisioned was: cell wall synthesis requires coordinated functions of a multi-
enzyme complex to catalyze elongation of glycan chains and cross-linkage of peptide chains, and binding 
of spermine to this complex via PBP2 elicits a conformational change to weaken interactions among 
enzymes in the complex and/or inhibit the TG activity of PBP2.  Given that a specific pbpB lesion confers 
resistance to spermine and spermine/oxacillin synergy on MuM, one would expect the TP domain of 
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PBP2 as potential target of spermine. However, we did not favor this hypothesis because TP-PBP2 is not 
essential for growth of MRSA in the presence of PBP2a. Moreover, the possibility of PBP2a per se as 
target of spermine could also be excluded because the spermine effects also exist in MSSA in which 
PBP2a is absent, and MuM possessing PBP2a is resistant to spermine. Studies to elucidate the molecular 
mechanism for spermine effects based on the proposed model are currently in progress. 
pH sensitivity of MuM  
By truncating the TP domain of PBP2, MuM can only grow in a very limited pH range. The most striking 
difference between Mu50 and MuM in response to pH was under alkaline conditions (Figure 2.4), which 
may be related to the cell wall turnover rate by the following rationale. It has been reported that the 
murein hydrolase exhibits a much lower level of activities in acidic conditions (119). Therefore, it is 
anticipated that alkaline conditions can speed up murein hydrolysis, which could have a more severe 
impact on MuM due to its weakened cell wall structure. 
 
On the other hand, MuM also shows sensitivity to acidic pH. It is known that the trans-membrane pH 
gradient is essential for the uptake of amino acid in S. aureus (74). The ability of MuM to adjust trans-
membrane pH gradient may be reduced due to the PBP2 mutation and concurring cell wall anomaly, 
which could be a possible reason for its reduced growth rate when pH is lower than 7.  One explanation 
can be derived from the fact that PBP2a is not detectable when grown at pH 5.2 (36, 65), and therefore 
MuM without a functional TP of PBP2 would encounter severe cell wall defects at acidic conditions.   
 
In summary, several lines of evidence support PBP2 as the potential target of spermine in sensitization of 
S. aureus to β-lactams. Absence of the TP domain in spermine-resistant MuM may liberate PBP2 from 
spermine interference, and concomitantly cooperate with PBP2a to continue functional on exposure to β-
lactams. The altered phenotypic properties and transcriptional adaptations could be the compensatory 
effects triggered by mutated PBP2 on cell wall composition. Future studies on the molecular mechanism 
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of spermine interactions with the proposed PBP2-associated multi-enzyme complex in cell wall synthesis 
hold great potentials on the development of new therapeutics for MRSA infections. 
PBP2 is not the only Spm-resistant determinant for Spm-resistant (SpmR) mutants  
Besides MuM, nine more independent SpmR mutants were also isolated and characterized (Table B.1). 
Although displaying different genotypic and phenotypic properties from MuM (Figure B.1, B.2), those 
SpmR all show resistance to both Spm and Spm/ β-lactam synergy (Table B.2). Notably, in the mutants 
derived from RN4220, each strain has more than one mutation with some of which shared in two strains 
(Table B.3). Therefore, products of those mutated genes may act cooperatively to counteract the Spm 
effect. Meanwhile, concerning the scope of mutated genes, we may infer that instead of locating a single 
and defined target, the role of Spm to S. aureus could be multifarious and complex. Details for 
characterization of these mutants are included in Appendix B. 
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CHAPTER 3: ANALYSIS OF SPERMINE-DEPENDENT SYNERGY WITH β-LACTAMS ON 
CELL WALL SYNTHESIS 
3.1 INTRODUCTION 
As described in Chapter 2, an MRSA mutant may become Spm-resistant with no Spm/β-lactam synergy 
by a specific mutation on PBP2 that possesses an intact N-terminal TGase domain but no C-terminal 
TPase domain. It strongly supports the hypothesis that Spm may interfere with PBP(s) or the coordinated 
complex in cell wall synthesis. Therefore, experiments were designed to test this hypothesis in the 
following aspects with cells upon challenge by Spm or β-lactam alone or in combination: 1) the cell wall 
composition; 2) expression of PBPs on transcriptional level and translational levels. Meanwhile, the 
recombinant PBPs of S. aureus were constructed, purified, and analyzed via biochemical approaches to 
test the possible interactions between Spm and PBPs. 
 
3.2 MATERIALS AND METHODS 
Bacterial strains, plasmids, and growth conditions 
S. aureus Mu50 (ATCC700699), E. coli DH5α (Bethesda Research Laboratories) and Top10 (Invitrogen) 
were employed in this study. The plasmids used in this study are listed in Table 3.1, and primers are listed 
in Table S1. Both E. coli and S. aureus strains were routinely grown and maintained in the Luria-Bertani 
(LB) medium. When required, the LB medium was buffered with 20mM Tris-HCl at the indicated pH. 
For E. coli, ampicillin was added to the medium as necessary at 100μg/ml. 
Analysis of cell wall composition 
MRSA strain Mu50 was grown in LB broth (pH 8.0, w/ 20mM Tris-Cl) at 37 °C with aeration. At OD600 
of 0.5, cultures were supplemented with 0.5 mM spermine (Spm) and/or 1 ng/μl oxacillin (Ox), and cell 
growth was continued for 4 hours before harvest. Isolation of cell wall peptidoglycans and the analysis of 
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the muropeptides by reverse-phase HPLC were carried out by CeCo Labs from Tubingen University, 
Germany (www.cecolabs.de).   
Protein cloning, expression, and purification 
The pbp1 (or pbpA), pbp3 (or pbpC), pbp4 (or pbpD) gene lacking the sequence forthe N-terminal signal 
peptide and the putative transmembrane (TM) domain (at N-terminus of PBP1 and PBP3 andC-terminus 
of PBP4)was amplified from gDNA of MRSA Mu50 using Phusion polymerase (NEB). The resulting 
PCR product was digested with PstI/EcoRI and cloned into the corresponding sites in the expression 
vector pBAD/HisD, giving rise to pH6N-PBP1, pH6N-PBP3, and pH6N-PBP4. The constructs encode 
the fusion of a hexa-histidine tag to the N-terminus of PBP1, PBP3, or PBP4. The resulting plasmids 
express the recombinant proteins which cover residues M37-D744 for PBP1), Q44-K691 for PBP3), and 
T25-H400 for PBP4, respectively. 
 
Recombinant plasmids were also constructed to express the periplasmic polyamine-binding protein PotD 
without signal peptide) and the transcriptional regulator PotR of the potABCD operon.The PCR products 
for these constructs were digested with HindIII and EcoRI, respectively, and cloned into SmaI/HindIII 
and SmaI/EcoRI sites of pBAD/HisD (5’ blunt end of PCR product ligating to SmaI site on the vector), 
obtaining pH6NnSP-PotD and pH6N-PotR with a hexa-histidine tag fused to N-terminus of PotD and 
PotR. 
 
Recombinant strains of E. coli Top10 harboring plasmid of interest were grown at 30°C in LB medium 
containing 100 μg/ml ampicillin. When OD600 reached 0.6 to 0.8, the cultures were supplemented with 0.2% 
arabinose followed by an additional 4 hours of growth. Cells were harvested by centrifugation, 
resuspended in  buffer A (20 mM sodium phosphate [NaPi] buffer, pH 7.4, 500mM NaCl) containing  a 
cocktail of EDTA-free protease inhibitors (Roche), and disrupted by French press at 17,000 psi. After 
centrifugation at 20,000 × g for 30min at 4°C, the soluble fraction was applied to a HisTrap HP column 
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(GE) pre-equilibrated with Buffer A.  Unbound proteins were washed off the column with 5 column 
volumes of Buffer A, and the bound proteins were then eluted by increasing conc. of imidazole (final 
conc. 500 mM) in a gradient manner. The target fractions were pooled together and concentrated using an 
Aminco Ultra-4 centrifugal filter unit (Millipore) and  change the buffer to 20 mM Tris-HCl (pH 7.6). 
 
For PBP2, the pbp2 (or pbpB) gene was PCR amplified (Phusion, NEB) from Mu50 genomic DNA with 
primer pairs see Table S1. The region encodes amino acids W59 to S716 omitting the N-terminal 
cytoplasmic tail, transmembrane domain, and 11 amino acids from the C-terminus. The PCR product was 
digested with BspHI/SmaI and subcloned into NcoI/SmaI sites of the expression vector pBAD-HisE. The 
resulting plasmid pH6C-PBP2 was introduced into in E. coli Top10 for expression for a recombinant 
PBP2 with a C-terminal hexa-histidine tag.  
 
PBP2 was expressed after induction of a log-phase culture with 0.2% arabinose for 4 hours at 30°C. The 
cells were broken with a French press at 17,000 psi in Buffer A with Complete EDTA-free protease 
inhibitors (Roche) as described above. After centrifugation at 20,000g × for 30min, freely soluble proteins 
were decanted, and the pellet was resuspended in Buffer A containing 20mM CHAPS, 10% glycerol, 0.1% 
Sarkosyl (as detergent-containing His Buffer) and adjust pH to 9.0 by 1N NaOH with stirring at 4°C.  The 
solublized fusion protein was then loaded onto HisTrap HP column (GE) which was washed extensively 
with the detergent-containing Buffer A and then eluted in a stepwise manner using detergent-containing 
Buffer A with 500mM imidazole. The target fractions were pooled together and concentrated using an 
Aminco Ultra-4 centrifugal filter unit (Millipore) to change the buffer to 20 mM Tris-Cl (pH7.6). 
 
For PBP2a, the mecA gene lacking the first 69 bases for its N-terminal anchoring region of 23 amino 
acids was amplified from Mu50 gDNA and cloned into NcoI/HindIII site of pBAD/HisA. The resulting 
plasmid pPBP2a encoding no hexa-histidine tag, was further transformed into E. coli Top10 for 
overexpression. PBP2a was expressed after induction of a log-phase culture with 0.2% arabinose for 4 
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hours at 30°C. Cells were suspended in Q buffer (20mM Tris-Cl, pH7.6) containing complete EDTA-free 
protease inhibitors (Roche), and disrupted by French press at 17,000 psi. After centrifugation at 20,000g × 
for 30min, the supernatant was subjected to ammonium sulfate fractionation. The fraction precipitated by 
30% saturation was dissolved in Q buffer, and desalted by Aminco Ultra-4 centrifugal filter unit 
(Millipore). The concentrated protein sample  was diluted with Q buffer and applied to HiTrap Q HP 
column (GE) equilibrated with same buffer. Following gradient elution with Q buffer containing 1M KCl, 
fractions containing target protein were combined and desalted again with Aminco Ultra-4 centrifugal 
filter unit to change the buffer to 20 mM Tris-HCl (pH 7.6). 
Construction of expression-vector pBAD-HisE 
The primer pairs hisF-5’ GGGCATCATCATCATCATCATTGAATTCTGC 3’ and hisR-5’ 
GCAGAATTCAATGATGATGATGATGATGCCC 3’ were annealed and digested by SmaI/EcoRI, to 
replace the SmaI-EcoRI region of pQF50. The resulting plasmid pQF53 was further digested with 
NcoI/EcoRI to release the partial MCS carrying the His6 region, which was used for replacing the NcoI-
EcoRI region of expression vector pBAD-HisC (Invitrogen). The derived construct pBAD-HisE contains 
the translational initiation site (at NcoI site) followed by MCS (SalI, XbaI, BamHI, SmaI) and the 
sequence for a hexa-histidine tag.  
Bocillin labeling of PBPs  
For labeling of purified PBPs, the protein samples (0.04 µg in 20 µl of 20mM Tris-Cl pH8.0) were 
incubated with Bocillin of indicated conc. for 30 min at 37 °C with gentle shaking. For labeling with 
bacterial lysates, the culture of log-phase S. aureus (10 ml) was harvested and the cell pellet was 
suspended in 200 µl the lysis buffer (50mM Tris pH7.5, 50mM NaCl, 5-10 µl of lysostaphin (10mg/ml), 
5µl of DNaseI (10 U/µl), 5 ul of RNase A (200 µg/ml) with gentle shaking for 15-20 min at 37 °C, 
followed by the addition of Bocillin to a final concentration of 5µM and incubated at 37 °C for 30 min.. 
For the concentration-dependent experiments, the Bocillin conc. ranges from 0.25-16µM. If needed, 
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samples were pre-incubated with Spm for 30 min at 37 °C prior to Bocillin labeling. After Bocillin 
labeling, samples were mixed with Laemmli sample buffer and boiled for 5 min prior to SDS-PAGE.  The 
gel was rinsed with water immediately after electrophoresis and scanned with Typhoon scanner with 
excitation wavelength at 488 nm and emission wavelength at 530 nm. The intensity of the bands was 
quantified by Image Quant software. 
In vivo 14C Spm labeling of S. aureus lysate 
The cells from a 10-ml culture of mid-log phase S. aurues in LB medium (pH8.0) were immediately 
collected by centrifugation and resuspended in 100 µl of Tris buffer (20mM ,pH8.0). A cocktail of 2 µl of 
0.5M cold Spm and 1µl of 1mM 14C Spm (0.1mCi/ml, 100mCi/mmol) were immediately added, followed 
by a 30 min incubation at 37 °C. Lysostaphin (2 µl; 10mg/ml) was then added and the samples were 
incubated at 37°C for an additional 20 min; samples were also treated with of DNase I (1 µl; 10U/µl) and 
of RNase A (1 µl; 200 µg/ml) in some experiments. After lysis, Laemmli sample buffer was added and 
the samples were boiled for 10 min, followed by electrophoresis on 10% SDS-PAGE. The gels were dried 
and subjected to autoradiography. 
14C Spm labeling of overexpressed proteins in vivo 
Aliquots of E. coli culture (1.5 ml) of overexpressed recombinant proteins were harvested by 
centrifugation. The resulting pellet was resuspended in 30 µl of Tris buffer (20mM; pH8.0), added with a 
mix of 2 µl 14C Spm (1 mM) / 2 µl cold Spm (2.5 mM) and incubated at 37°C for 30 min with gentle 
shaking, followed by the addition of lysozyme (3 µl ; 20ng/µl), DNase I (1 µl ; 10U/µl) and RNase A (1 
µl; 2 mg/ml) for additional incubation of 30 min. The lysates were then added with Laemmli sample 
buffer and boiled for 5 min prior to SDS-PAGE analysis. After electrophoresis, the gels were dried and 
subjected to autoradiography. 
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14C Spm labeling of purified proteins in vitro 
The purified protein (10 µl of 0.04 µg/µl in 20mM Tris-Cl, pH8.0) was incubated with a mix of  14C Spm 
(1mM; 2 µl) and cold Spm (2.5mM; 2 µl) for 30 min with gentle shaking at 37°C. Then the samples were 
added with Laemmli sample buffer and boiled for 5min prior to SDS-PAGE. After electrophoresis, the 
gels were dried and subjected to autoradiography. 
DARTS (Drug Affinity Responsive Target Stability) 
The purified protein (1 µg in 20 µl of 50mM Tris-Cl, pH8.0, 50mM NaCl, 10 mM CaCl2) was incubated 
at 37°C with or without 1 mM Spm for 25 min,  then subjected to trypsin digestion (0.075 µg) at 25°C for 
a specified period of time as indicated in results. The reaction was stopped by immediate addition of 
Laemmli sample buffer and boiled for 10min, followed by SDS-PAGE.  
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Table 3. 1 Plasmids used in Chapter 3 
   
Plasmids  Relevant characteristics Source or reference 
 pBAD/HisA Expression vector, Amp
r Invitrogen 
 pBAD/HisD Expression vector for producing N terminal His tag fusion, Amp
R (69) 
 pBAD/HisE Expression vector for producing C-terminal His fusion, Amp
R This study 
 pH6N-PBP1 pBAD/HisD expressing N-His-PBP1 This study 
 pH6C-PBP2 pBAD/HisE expressing C-His-PBP2 This study 
 pH6N-PBP3 pBAD/HisD expressing N-His-PBP3 This study 
 pH6N-PBP4 pBAD/HisD expressing N-His-PBP4 This study 
 pPBP2a pBAD/HisA expressing no tag PBP2a This study 
 pH6NnSP-PotD pBAD/HisD expressing N-His-no signal peptide PotD This study 
 pH6N-PotR pBAD/HisD expressing N-His-PotR This study 
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3.3 RESULTS 
Synergy between spermine and oxacillin reduces the degree of cross linkage on cell wall 
To determine the composition and degree of cell wall cross-linkage in spermine/oxacillin-grown cells, 
peptidoglycan was digested with M1 muramidase and the fragments were analyzed by HPLC. 
Examination of MRSA Mu50 grown in the presence of Spm (0.5mM) alone, Ox (1ng/µl) alone, or their 
combination, revealed no major changes on the biochemical composition of PG (Figure 3.1). However, 
differences were noted in the degree of cross-linking between glycan chains within the samples. The 
combination treatment results in a more depressed hump (retention time 110min and after) in this sample 
while samples of Spm- or Ox-alone do not cause any significant changes on the chromatograms (data not 
shown). A chromatogram with a depressed humpalso occured when S. aureus encounters high dose β-
lactams that block the biochemical functions of PBPs(23). Since PG cross-linking is catalyzed by PBPs, 
this result strongly suggests an enhanced PBP inactivation by Oxa/Spm synergy. 
 
The overall contribution of PBPs in cell wall synthesis in the case of Oxa/Spm synergy can be affected in 
multiple levels: 1) transcription and translation; 2) the binding affinity with β-lactams; 3) the enzymatic 
activity, which may result from irregular conformation, incorrect localization, masked active sites, etc. To 
clarify if PBP2a or the PBPs complex is involved in the synergism, we tested a) whether Spm suppresses 
PBPs’ expression; b) whether Spm enhances the PBPs-β-lactam binding; c) whether Spm can directly 
interact with PBPs to influence their activities. We did not evaluate whether Spm can delocalize PBP(s) 
or prevent their recruitment to the septum due to some technical limitations. 
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Figure 3. 1 Chromatograms of peptidoglycan analysis by HPLC. 
Effect of Spm/β-lactam on the muropeptide composition and degree of cross-linking of peptidoglycan 
extracted from S. aureus Mu50. Purified peptidoglycan preparations from cells grown in the presence or 
absence of Spm or oxacillin or their combo were digested with muramidase and the digestion products 
separated by HPLC. 
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Figure 3. 2 Transcript levels of pbp genes exposed to Spm and Ox alone or in combination. 
Spm(1mM spermine), Ox (16ng/μl oxacillin), Spm+Ox (1mM spermine + 16ng/μl oxacillin), recorded by 
GeneChip (Affymetrix) 
 
 
 
 
Figure 3. 3 PBPs profiles of S. aureus exposed to Spm during growth. 
Mu50 was grown in the presence of various concentrations of spermine. Cell lysates were labeled with 
Bocillin to identify PBP1-4, or subjected to Western blot to detect PBP2a. 
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Spm does not affect PBPs expression 
To determine the gene expression of PBPs upon Spm or synergy, we performed microarray analysis in 
MRSA Mu50 treated with Spm (1mM), Ox (16ng/µl), or in combination for 2 hours. Figure 3.2 shows the 
signal intensities of different pbp expression under the tested conditions.  No significant differences can 
be detected between untreated and treated transcripts, suggesting low-dose Spm by itself or in 
combination with β-lactams may not affect the pbp transcription. Next, to examine whether Spm can 
influence the PBPs production, lysates from Mu50 grown in the presence of different concentrations of 
Spm (0.5mM, 2mM, 10mM) were subjected to Bocillin labeling (for detection of PBP1-4) or Western 
blot (for detection of PBP2a). Again, no significant changes in the quantities of any PBPs can be observed 
(Figure 3.3). These results indicated Spm may not affect PBPs expression either at the transcriptional or 
translational level. 
Spm does not affect acylation of PBPs by Bocillin  
To evaluate whether Spm can enhance binding of β-lactams toPBPs binding during synergy, PBPs in S. 
aureus lysate or purified PBPswere incubated with Bocillin, a fluorescent β-lactam derivative, with or 
without Spm treatment. The binding affinities were estimated by measuring the fluorescence intensities of 
acylated PBPs by Bocillin. To be specific, firstly the lysates from Mu50 grown in the medium free of 
Spm or Oxa were pre-incubated with 0.5mM Spm and subjected to labeling by Bocillin of indicated 
concentrations. The binding kinetics of Bocillin to PBPs, as illustrated in Figure 3.4A, were unaffected by 
the presence of Spm. 
 
Next, purified PBPs were used to study the β-lactam-PBP binding affinity, individually or in combination. 
From the monophasic saturation curve obtained by the binding of Bocillin at different concentrations, the 
affinity of Bocillin for different PBP was calculated (Figure 3.4B). The notably higher dissociation 
constant (Kd) of PBP2a than those of other PBPs is consistent with its low affinity to β-lactams and the  
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resultant high β-lactam MIC for MRSA. Moreover, when comparing the individual Kd values between 
Spm treated and untreated samples, no significant variations can be detected. Coomassie staining of the 
same gel ensured no variations in protein amount between samples (data not shown). Collectively, these 
two lines of data both suggest Spm may not affect PBP acylation by β-lactams. 
Formation of Spm-PBPs conjugates  
Spm is a potent nucleophile at high pH, as evidenced by the formation of a Spm-Ox adduct in our recent 
report (121) (Figure 2.3 in Chapter 2). At the same time, growth inhibition by Spm and the synergy effect 
of Spm and β-lactams become more effective when pH is increased (Figure 2.2 in Chapter 2). Since PBPs 
of S. aureus reside outside of the cells where the electron numbers of amine are readily affected by 
environmental pH to make Spm become a nucleophile, we tested if Spm can form chemical conjugates 
with PBPs. Crude extracts of E. coli expressing recombinant PBPs were mixed with 14C Spm as described 
in Materials and Methods, followed by SDS-PAGE and exposure to the phospoimage plate. A carboxyl 
esterase Est30 was used as control. As shown in Figure 3.5A, unexpectedly, all of the tested proteins were 
labeled with radioactivity, indicating the formation of non-specifi Spm-protein conjugates.  
 
To further verify these results, similar experiments were performed on each purified PBP. Much less 
amount of purified PBPs was used compared to that in the extracts (as demonstrated with Commassie 
staining of the same gel), and no visible radioactive-labeled protein band can be detected (Figure 3.5B). 
These negative results suggest low efficiency in the formation of Spm-protein conjugates; alternatively, it 
is possible that the formation of conjugates requires cooperation with other factors which are present in 
cell extract but absent in purified protein solutions. 
 
Also, we tried to use 14C Spm to directly label S. aureus lysate (Figure 3.5C), and no distinct band can be 
detected with the lysate pre-treated with DNase and RNase. However, radioactive signals appeared as a 
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smeared block of high molecular weights when the lysate without nuclease treatment was used in the 
reaction. These results may imply possible interactions of Spm with DNA or RNA.   
No change in the trypsin digestion pattern of purified PBPs by the presence of Spm  
In comparison to PBPs alone, binding of Spm to PBPs may cause conformational changes, and hence the 
sensitivity of ligand-protein complexes against protease digestion. So, we looked for possible 
conformation changes of PBPs due to Spm interaction by the DARTS (drug affinity responsive target 
stability) method. Purified PBP was pre-incubated with or without Spm, subjected to trypsin digestion 
following a time course, and separated by SDS-PAGE.  The unrelated carboxylesterase Est55 served as 
control. As shown in Figure 3.6, for all tested proteins, no significant difference on the digestion pattern 
can be observed regardless of Spm treatment. Although these results imply the inability of Spm to change 
the protein conformation in vitro (under test conditions), we may not rule out the possibility that other 
unknown factors may be required to facilitate the Spm-protein interaction, as observed in Figure 3.5A.  
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Figure 3. 4 Binding kinetics of Bocillin to PBPs in the presence or absence of Spm. 
(A) in vivo analysis using PBPs of S. aureus lysate. Mu50 was grown in Spm-free medium. The lysates 
were pre-incubated with or without Spm, and labeled by various amount of Bocillin. 
(B) in vitro analysis using purified PBPs, for determination of PBPs - Bocillin affinity in the 
presence or absence of spermine. Purified PBPs (alone or in cocktail) were pre-incubated with or 
without Spm (1mM) and labeled by various amounts of Bocillin 
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Figure 3. 5 14C Spm labeling of proteins 
(A)proteins  in vivo (E.coli lysate with overexpressed protein);   
(B)proteins in vitro (protein after purification);  
(C)cell lysate of S. aureus.   
Samples were incubated with 14C spermine and separated on SDS-PAGE; dried gel was exposed to 
phosphor image plate for radioisotope detection 
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Figure 3. 6 DARTs analysis with pure PBPs. 
Purified PBP or control (Est55) was incubated with or without spermine and digested with trypsin.  The 
period of time for trypsin digestion differed among proteins: PBP1, 4min; PBP2, 10min; PBP3, 10min; 
PBP4, 10min; PBP2a, 20min; Est55, 10min. 
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3.4 DISCUSSION 
Spm may potentiate β-lactam efficacy by perturbing the functional cooperation of PBPs  
The PBP2 mutant strain MuM became Spm-resistant and showed no Spm/β-lactam synergy, suggesting 
PBPs could be the target for Spm. In line with this, the reduced PG crosslinking by a combination of low 
dose Spm and oxacillin further supports the hypothesis of Spm perturbing cell wall integrity in favor of β-
lactam efficacy. However, a series of experiments investigating Spm effects on PBPs, the β-lactam targets, 
implies that Spm does not appear to suppress the PBPs expression or alter their interactions with β-
lactams. Even so, these results can not rule out the possibility that the enzymatic activities of PBP-
associated multi-enzyme complexes might be modulated directly by binding of Spm to the complexes or 
indirectly through delocalization or reconfiguration of the complexes on the membrane.  
Spm may perturb other cell wall related factors (instead of PBPs) to achieve the Spm/β-lactam 
synergy 
As described in Chapter 2 and Appendix B, in addition to strain MuM, we also characterized several other 
Spm-resistant mutants. Like MuM, these mutants lose the synergy effect of Spm and β-lactams, but 
genome resequencing identified mutations (on more than one locus per strain) other than pbp2 in these 
strains.  Therefore, it is possible that other mutation(s) may confer similar impacts as that of PBP2 defect 
in MuM to block the Spm target. In other words, other factors which can influence the cell wall turnover 
also have the potential to affect synergy.  Three hypothetical mechanisms were described below. 
 
1) One thought is that Spm may behave like vancomycin and other glycopeptides antibiotics, which 
inhibit the PG synthesis by binding to the D-Ala-D-Ala region of the stem peptide, and thus blocking both 
TGase and TPase activities of PBPs(112). If Spm works in this way, the resistant mutant may conquer the 
drug action by increasing intact D-Ala-D-Ala-carboxyl termini in the PG layer. These dipeptides may in 
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turn bind to and trap Spm in the layer and prevent it from reaching the target sites in the cell wall 
biosynthetic machinery at the cytoplasimic membrane.  
 
This hypothesis was supported by the significant induction of pbp4 under challenge of high dose Spm 
(Figure 5.5, Table S4). PBP4, which has both carboxypeptidase and transpeptidase activities in vitro, was 
hypothesized being an efficient carboxypeptidase over a transpeptidase in vivo. It is known the degree of 
cross-linking in cell wall is largely dependent on the ratio of cross-linked over free-stem peptides (100), 
with the latter primarily produced by the carboxypeptidase activity of PBP4 in S. aurues. Therefore, we 
speculate if Spm bind to the D-Ala-D-Ala of the stem peptide, the resultant shortage of cross-linking level 
and/or the excess of D-Ala-D-Ala may become a signal to induce pbp4 expression.   
 
2)  Spm-mediated perturbation of cell wall cross-linking may be related to changes in the secretion of 
autolysins. Autolysins are cell wall hydrolytic enzymes that play key roles in PG turnover, and the 
activity and retention of which are greatly influenced by the pH/charge characteristics of cell wall (95, 
111). The combination treatment of Spm andβ-lactam may decrease the net positive charge of the cell 
surface, e.g. reducing D-alanylation of cell wall-associated teichoic acid, which in turn reduces the 
autolysin processing and PG turnover, and ultimately the cell wall integrity.  
 
3) In dividing cells, PBPs-mediated transpeptidation and transglycosylation occur predominantly at the 
division septum, at which the substrate of PBPs for PG synthesis was restricted. Therefore, the number of 
PBPs on the cell membrane could be a crucial factor in determining the rate of cell wall synthesis. As 
such, we speculate that Spm may intercalate into the cell membrane, interfere with the trafficking of 
membrane-anchored PBPs or the associated enzymes, and delocalize cell wall synthetic machinery from 
the septum. By doing so, the adverse effect of Spm on cell wall synthesis may be further compounded by 
the presence of β-lactam. 
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CHAPTER 4: TRANSCRIPTOME ANALYSIS OF S. AUREUS IN RESPONSE TO THE 
SYNERGISTIC EFFECT OF SPERMINE AND OXACILLIN 
 
4.1 INTRODUCTION 
Combination of two drugs may inhibit bacterial growth in more complicated ways than the single drug 
does. As for our case, there are various possible mechanisms by which Spm/β-lactam synergy can arise: (i) 
they both inhibit a common biochemical pathway-cell wall synthesis; (ii) Spm inhibits the protective 
enzyme against β-lactams, which is PBP2a in MRSA; (iii) β-lactam enhances the uptake of Spm to 
intensify its toxicity to the cell; (iv) Spm amplifies the secondary effects imposed by β-lactams, e.g. 
producing  ROS and triggering oxidative-damage cellular death pathway.  In short, the synergy of Spm 
and β-lactams may function by Spm facilitating β-lactams or β-lactam enhancing Spm attack on unknown 
targets, or the formation of a new structural configuration that makes the common target more vulnerable 
to attack by Spm or β-lactams. Therefore, besides exploring how Spm could affect β-lactam sensitivity in 
S. aureus, monitoring the global changes in gene expression patterns over a range of conditions, in our 
case Spm or Ox alone and Spm/Ox combination, may provide us a better insight of how two agents might 
affect each other to enhance the antibacterial effectiveness. 
 
4.2 MATERIALS AND METHODS  
Transcriptional profiling conditions (for low concentration of Spm, Ox, or Spm/Ox)  
Overnight grown cultures of S. aureus Mu50 were used to inoculate 50ml LB broth (pH8.0) and grown at 
37 ºC with shaking at 250rpm. The cultures in log-phase (OD600 of 0.5) were exposed to the following 
compounds for 2 hour exposure before harvest: Spm (1mM), Ox (16ng/µl), and a combination of Spm 
and Ox. The working concentrations of Spm and Ox were chosen based on the noticeable synergistic 
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effect at which they gave rise to. Cultures free of exogenous Spm and Ox served as control. Experiments 
were carried out in two independent batches of cultures.  
RNA isolation  
The cells from fresh cultures were harvested by centrifugation at 20 ºC for 2 min with 12,000 rpm. Cell 
pellets were suspended with 1 ml of suspension buffer (20mM Tris-Cl, pH7.5, 50mM NaCl, 10mM 
EDTA) and 2 ml of RNAprotect Bacteria Reagent (QIAGEN), and mixed immediately by vortexing for 5 
seconds. The cell suspensions were then incubated for 5min at room temperature followed by 
centrifugation for 10min at 12,000 rpm. After decanting the supernatant, the cell pellets were resuspended 
in 3 ml of suspension buffer and added with 10 µl of lysostaphin (10mg/ml) to weaken cell wall. RNA 
extraction was then carried out using hot phenol extraction method. Contaminated genomic DNA was 
removed using RNase-Free DNase I (Pierce) coupled with DNase I buffer (USB). The treated sample was 
applied to an RNeasy Mini column (QIAGEN) to recover RNA. The quality of these RNA samples was 
monitored by agarose gel electrophoresis, and RNA quantity was measured by UV spectrophotometry.  
DNA Microarrays 
The purified RNA sample was subjected to cDNA synthesis through random priming, reverse 
transcription, and removal of RNA. The purified cDNA was treated with DNase I for fragmentation, 
followed by terminal labelling with biotinated dUTP. The labelled cDNA sample was hybridized to 
GeneChip® of S. aureus Genome Arrays (Affymetrix), which were subsequently washed, stained and 
scanned. All the procedures followed the GeneChip® Expression Analysis Technical Manual. For 
qualitative presentation, the processed and normalized signals from the array were subdivided into four 
categories according to the range of intensities, and were represented as follows accordingly (Table S3, 
S4 of Appendix A): •100-500, •• 500-1500, ••• 1500-4500, •••• 4500-50000. 
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4.3 RESULTS  
To gain insight into the cellular responses to the synergistic effects of Spm and β-lactam, DNA 
microarrays experiments were conducted in MRSA Mu50 growing in the LB medium with following 
supplements as Experimental Group: 1mM Spm (sample S), 16 ng/µl Ox (sample O),  1mM 
Spm+16ng/µl Ox (sample SO). The cultures in the exponential phase were exposed to the indicated 
supplements for two hours before harvest for RNA purification, and the culture without exposure to any 
supplement (sample N) served as Control Group. 
 
Once the signals of gene expression from each sample were obtained as described in Materials and 
Methods, data analysis was conducted by comparing three samples in the Experimental Group with 
sample N in the Control Group to identify genes of statistically significant changes in expression levels. 
The following criteria were applied:  (1) p value ≤0.05, (2) absolute fold change ≥2, and (3) signal 
intensity > 100 on either the experimental set (for up-regulation sorting) or control set (for down-
regulation sorting). By comparing S with N, O with N, and SO with N, a total of 507 probes was 
identified that showed changes of statistical significance. After removing those probes without assigned 
ORF ID (compiled from genome annotations of four strains: Mu50, N315, COL, NCTC8325), the 
number of ORFs trimmed down to 460, with 174 from S/N, 74 from O/N, and 408 from SO/N, 
respectively.  
Quantitative analysis of ORFs influenced by Spm, Ox, Spm+Ox 
Cross examinations of the S/N, O/N, and SO/N gene lists revealed seven possible overlaps, as illustrated 
by the Venn diagram in Figure 4.1A. In the Experimental Group SO imposed the broadest impact on gene 
expression among three treatments, followed by S and O in this order (Figure 4.1B). Although it was 
anticipated that the SO gene list overlaps most genes in the S list and O list, a substantial number of genes 
was identified exclusively in response to the combination of Spm and Ox (236 out of 408 genes in the 
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‘SO-only’ category of Figure 4.1B). Considering the drastic killing effect brought by Spm/Ox synergy, it 
is reasonable to speculate that this group of 236 genes holds up the most useful information regarding the 
primary target(s) or secondary effects elicited by Spm/Ox synergy. In addition, it is interesting to note that 
S and SO co-regulated 128 genes while O and SO only co-regulated 21 genes. Furthermore, genes in the 
SO-only category do not overlap with those in the reported list of cell wall stress (110). These results 
strongly implied that the Spm/Ox synergy does not amplify the adverse effect of Ox to a degree that 
triggers cell wall stress. Contrarily, this synergy might impose a stronger damage by Spm in the presence 
of Ox than Spm alone, or alternatively a new type of stress response that has never been reported before. 
Functional classification of ORFs influenced by Spm and/or Ox 
These 460 genes were further classified according to the COG functional categories 
(http://www.ncbi.nlm.nih.gov/COG/) (Figure 4.2). In general, Spm induced a number of genes involved 
in amino acid and carbohydrate metabolism as well as ion transport. Besides, several SigB-mediated 
virulence factors were down-regulated upon Spm addition.  Moreover, DNA repair-related genes also 
appeared in Spm regulated group, suggesting the potential interactions of Spm with nucleic acids through 
its charge property. For the 74 genes altered by Ox, one of the characteristics was the induction of 
translation-related genes, most of which encoding ribosomal units. Functional grouping of the 408 
Spm/Ox regulated genes revealed pleiotropic responses; nevertheless, as described above, those genes 
affected only by Spm/Ox combination but not by Spm or Ox alone could be more informative.  The 
characteristics of the 236 genes cluster include: 1) induction of metal transport, including both regulators 
and transporters; 2) induction of heat shock signature proteins (30), like Hrc, chaperone, protease; 3) 
reduction of energy metabolism pathways, involving glycolysis, fermentation, TCA cycle; 4) reduction of 
pigment production (crtMNOPQ); 5) reduction of amino acid metabolism, e.g. aspartate family, 
branched-chain amino acids, and histidine; 6) reduction of de novo synthesis of pyrimidine and purine 
nucleotides. Detailed description of these genes listed in Table S3.  
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A) Venn diagram of genes with significantly altered transcription (>2 fold) by 1mM spermine (S),   
16ng/μl oxacillin(O) or their combination (SO). 
B) All 7 possible intersections between three independent comparison sets revealed by A. Numbers in the 
table indicate the amount of genes regulated in each intersection.  
 
A                                                                 B     
                   
Figure 4. 1 Quantification and overlaps of different treatment regulated transcriptional profiles. 
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Figure 4. 2 Biological processes that are regulated in response to Spm and Ox alone or in 
combination. 
(A) spermine, (B) oxacillin, (C)spermine+oxacillin.  y axis represents the number of genes in each 
functional class. Red, up-regulation; blue, down-regulation. Genes with unknown functions were not 
included.  
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4.4 DISCUSSION 
From analysis of gene expression profiling, we gained more insights into the molecular mechanisms 
responsible for the synergistic effect of Spm/Ox combination. The first conclusion drawn from the 
experiment is that the combination deregulated a significantly higher number of genes as compared with 
Spm or Ox alone (Figure 4.1). This means a completely different array of genes and related pathways are 
implicated in the cell-killing effect by Spm/Ox synergy.  
Genes regulated by low dose Spm 
Down-regulation of surface-associated virulence factors and sigB controlled genes 
Transcriptome analysis revealed that low dose Spm results in down-regulation of genes for several 
virulence factors, including protein A (spa) and fibronectin binding proteins (sdrDE, fbnB) for host 
tissues attachment.  Although exogenous Spm was supposed to cause some stress on cells, it did not 
trigger the sigma factor B (SigB) regulon in response to general stress. Contrarily, the asp23, clpL, and 
csbD genes which are generally considered as signatures of the SigB-dependent stress regulon in S. 
aureus (78) were in fact down-regulated. There results indicate that the stress response to Spm is 
independent of SigB, and may even cause suppression of SigB. It is known that in S. aureus SigB controls 
a large regulon extending from multiple cellular processes to fine-tuning metabolism and virulence upon 
different environmental stresses (12, 78). In particular, SigB positively regulates adhesion to host cells, 
which is in agreement with the reduction of surface-associated virulence factors as described above.   
 
Up-regulation of iron/heme-acquisition pathways  
One major category of Spm-induced genes was related to iron/heme transport (35), including htsABC, 
fhuAVG, fer, etc. Heme or/and iron availability is essential for bacterial survival and virulence. Iron 
homeostasis is usually linked with oxidative stress; however in current study, no typical detoxifying 
enzymes against oxidative stress (e.g. katA, sodA) were affected by Spm, suggesting the need of heme 
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acquisition may not result from oxidative stress. In S. aureus, one essential function of heme is for the 
biosynthesis of cytochrome as component of the electron transport chain. Therefore, it would be 
interesting to speculate some connections may exist between Spm and heme-related respiration chain. 
One hypothesis is that Spm may cause damage on the electron transport chain through cytochrome 
destruction, which then turns on heme uptake to compensate for cytochrome deficiency.  
Gene regulated by low dose Ox 
It has been reported in S. aureus that high dose β-lactams trigger the cell-wall stimulon of a well-defined 
set of genes (110). However, transcriptome analysis with low dose Ox treatment in my study revealed a 
completely distinct pattern: the majority of representative genes in the cell wall stimulon were absent 
except for the induction of lrgAB.  Instead, there was down regulation of 21 genes in ribosomal protein 
synthesis. This striking feature is unusual because in general the suppression of protein synthesis 
apparatus is associated with lower growth rate; however, neglectable effects on growth can be observed 
by low dose Ox (Figure 5.3). What is more, such reduction on ribosome synthesis was alleviated by 
Spm/Ox combinational treat under which the growth was severely inhibited. It would be interesting to 
find out why  low-dose Ox can down-regulate ribosomal synthesis without inhibiting the growth while 
supplementing Spm, on the contrary, reverses the trend with a drastic adverse effect on growth.  
Genes regulated by the Spm/Ox combination 
A combination of low dose Spm and Ox may result in enhanced adverse effects by Spm, which could be 
similar to exposure to high dose Spm. As described in Chapter 5, DNA microarrays experiments were 
also conducted in Mu50 following exposure to 10 mM Spm. A total of 581 genes were identified 
exhibiting significant changes on the expression levels by high dose Spm. For simplicity, the list of 460 
genes described in this chapter was named Array I, and the one from Chapter 5 was named Array II. By 
comparing Array I and II, it was found that 207 genes were present in both arrays, of which 122 genes 
were exclusively responsive to the Spm/Ox combination (category 9 of Figure 4.3, not regulated by single 
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agent). In other words, genes responsive to the synergy effect overlap extensively with those to high Spm 
challenge. This observation prompted us to reconsider how the synergy effects occur: Spm enhancing β-
lactam effect or β-lactam enhancing Spm effect? It has been reported that high dose Ox induces cell-wall 
stress stimulon as primary effect and triggers oxidative stress as secondary effect. If Spm facilitated the 
primary action of Ox on cell wall, one would expect up-regulation of cell wall stimulon by the Spm/Ox 
combination, which does not appear to be the case in our data. However, the induced expression of iron 
uptake genes (Table S3) drew our attention: iron and H2O2 or its precursor superoxide (O2-) are required 
for the Fenton reaction to generate highly-destructive hydroxyl radicals (·OH), which trigger a common 
oxidative damage cellular death pathway (53, 54). Bactericidal antibiotics including β-lactams can trigger 
superoxide production through destabilization of the electron transport chain (54); in our transcriptome 
data, iron/heme acquisition was highly stimulated by both high dose (Table S4, Array II) and low dose 
Spm (Table S3, Array I). Therefore, one possibility was that the enhanced ferrous iron uptake by Spm, 
together with superoxide generated by β-lactams, significantly intensifies the Fenton reaction and 
subsequently causes cell death. 
 
On the other hand, it is still possible β-lactams augment Spm effects during the synergy. The extensively 
affected energy production pathways (glycolysis, fermentation, TCA cycle) by Spm may also perturb the 
electron transport chain. If so, one presumption is: β-lactam inhibited cell wall synthesis will disturb 
membrane potential, which cooperates with the possible deficiency on the electron transport chain 
endowed by Spm effect, to kill the bacteria.   
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                      Figure 4. 3 Summary of transcriptome from Array I and Array II.   
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CHAPTER 5: CHARACTERIZATION OF S. AUREUS RESPONSE TO SPERMINE TOXICITY 
 
5.1 INTRODUCTION 
Modulation of Spm tolerance 
Among common polyamines, spermine is the most potent bactericidal agent if left unmodified; thus, the 
intracellular concentration of Spm is tightly regulated at many control levels. In bacteria, Spm toxicity 
can be alleviated by degradation or uptake blockage. For degradation, Spm catabolic enzymes modify the 
amine groups and ultimately degrade the compound. Two common mechanisms have been reported to 
initiate Spm degradation: γ-glutamylation by γ-glutamylpolyamine synthetases (GPS) (Figure 1.1, Figure 
1.2) in P. aeruginosa and acetylation by Spd/Spm acetyltransferase (SSAT) in E. coli, B. subtilis, and a 
specific strain lineage of S. aureus. In P. aeruginosa, the presence of a specific GPS PauA2 is absolutely 
required for Spm catabolism. It works by converting the primary amine into carboxylic acid with the 
release of ammonium and recycling of glutamate. In S. aureus, the SSAT activity of SpeG from USA-300 
clones converts toxic Spm to non-toxic N-1 acetyl-Spm through acetylation, thus affording complete 
resistance to Spm. But in non-USA 300 lineage strains, like Mu50, they do not possess the speG gene 
encoding SSAT, hence being sensitive to Spm. As for uptake, polyamine transport has been characterized 
in more detail in Gram-negative bacteria. E. coli contains three different polyamine transport pathways. 
One of them is an ABC transporter (PotABCD), displaying preference for Spd uptake. In P. aeruginosa, 
SpuDEFGH which exhibit the highest similarities to the Pot transporter of E.coli, was demonstrated as the 
major inducible Spd/Spm uptake system. In Gram-positive S. aureus, it contains a five-gene operon: a 
regulator and a four-gene encoding putative ABC transporter for polyamines with a high degree of 
sequence homology to the potABCD in E. coli (Figure 5.7). However in S. aureus, how the 
polyamine/Spm transport is regulated and whether the Pot system is responsible for the uptake, remain 
unknown. 
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Of note, although Spm is toxic to the cell, many bacteria, like P. aeruginosa, still have the capability to 
take up Spm from their environment and use it as nutrient. Therefore, it is conceivable an inducible 
uptake system exists in those bacteria to cooperate with the active Spm catabolism. On the other side, for 
the bacteria without the Spm catabolism, the polyamine-transport system may evolve to reduce the Spm 
uptake, e.g. by decreasing the binding affinity to Spm or becoming non-inducible upon Spm.  Based on 
this hypothesis, we are interested to know:  for most S. aureus strains which do not have an active Spm 
catabolic system, how the spermine transport is modulated to maximally enhance the bacterial tolerance 
to Spm toxicity?  
 
The target(s) of Spm toxicity 
With multiple amines, Spm is very likely to mediate cell physiology by interactions with different 
molecular targets. In P. aeruginosa, blocking GPS pathway by knockout of pauA2 will make the cell 
become sensitive to Spm, indicative of the intracellular target of Spm toxicity. Of note, deleting the Spm 
uptake system SpuDEFGH in P. aeruginosa also can increase the bacterial susceptibility to Spm, 
suggesting another Spm-dependent cytotoxic target may exist in the periplasm.  In fact, it was 
demonstrated before polyamine (cadavarine) can facilitate the structural linkage between peptidoglycan 
and the outer membrane .in Selenomonas ruminantium(55), substantiating the hypothesis that potential 
target of polyamine/Spm may exist in the periplasm. Thus, we are interested to explore where the Spm-
dependent targets locate, inside or outside of the cell; and what kind of stress responses can be triggered 
by the Spm toxicity in S. aureus. 
 
Taken together, in this chapter, we applied the transcriptomic approach to investigate the cellular response 
to Spm stress and further characterize Spm-responsive candidates to elucidate the regulation of Spm 
homeostasis in S. aureus 
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Table 5. 1 Bacterial strains and plasmids used in Chapter 5. 
 
 
 Relevant characteristics 
Source or 
reference 
Strains  
 E.coli  
 
DH5α 
F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-
1 gyrA96 relA1 
Bethesda 
Research 
Laboratories 
Top10 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1araD139 Δ(ara leu) 7697 galU galK rpsL 
(StrR) endA1 nupG 
Invitrogen 
S. aureus  
 
RN4220 Restriction-deficient derivative of S. aureusNCTC832-4 R.Novick 
Mu50 MRSA, VISA, wild-type strain (60) 
HG003 S. aureus NCTC8325 derivative, rsbU and tcaR repaired (39) 
COL HA-MRSA (33) 
JE2 USA300 LAC (CA-MRSA) strain cured of the three plasmids Nebraska 
Transposon 
Mutant 
Library, 
(NARSA 
repository) 
NE658 Bursa aurealis mariner-based, erythromycin resistance-
expressing transposon within gene encoding potD. 
HGΔpot::Km HG003 potRABCD null mutant; Kmr This study 
 
Plasmids   
 
pCN38 Low-copy-number E. coli-S. aurues shuttle vector, AmpR, CmR R.Novick 
pCNspeG pCN38 with speG under the control of its endogenous promoter This study 
pCNtetM pCN38 with tetM under the control of its endogenous promoter This study 
pUCtetM pUC18 carrying tetM gene This study 
pCN56 High-copy-number E. coli-S. aureus shuttle vector with GFP as 
reporter genes for promoter-gene fusions 
This study 
pMAD-CM E. coli-S. aureus shuttle vector with a thermosensitive origin of 
replication for Gram-positive bacteria; AmpR, EmR, CmR, lacZ 
(75) 
pMADCMΔpot::Km pMAD-CM with upstream of potR and downstream of potD, 
linked by Km cassette from pCN34(R. Novick) 
This study 
pCNPpotR::gfp pCN56 with upstream region of potR This study 
pCNPpotRA::gfp pCN56 with upstream region (including potR) of potA This study 
pBAD/HisD expression vector for producing N terminal His tag fusion, AmpR (69) 
pPotR pBAD/HisD expressing native PotR This study 
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5.2 MATERIAL AND METHODS 
Bacterial strains, plasmids, and growth conditions 
The bacterial strains and plasmids used in this study are listed in Table 5.1, and primers are listed in Table 
S1. Both E. coli and S. aureus strains were routinely grown and maintained in the Luria-Bertani (LB) 
medium. When required, the LB medium was buffered with 20mM Tris-HCl at the indicated pH. 
Antibiotics were added to the medium as necessary at the following concentrations: ampicillin, 100μg/ml 
for E. coli; kanamycin, 25μg/ml for E. coli, 50μg/ml for S. aureus; erythromycin, 10μg/ml for S. aureus; 
chloramphenicol, 10μg/ml for S. aureus.  
Transcriptional profiling conditions and microarray (for high concentration of Spm) 
Overnight grown cultures of S. aureus Mu50 were used to inoculate 50 ml LB broth (pH8.0, Tris-Cl 
20mM) and grown at 37ºC with shaking at 250rpm. Exogenous Spm (final conc.10mM) was added to the 
culture in log-phase (OD600 of 0.5) and RNA samples were collected in a time-course manner (15min, 
30min, 60min). RNA samples from cultures without Spm exposure were served as control.  The 
subsequent Microarray experiment was conducted as described in Chapter 4.  
Microarray validation by quantitative reverse transcription-PCR (qRT-PCR) 
qRT-PCR was used to validate microarray data and to analyze the effects of different polyamines on 
candidate genes. Total RNA was prepared as described above for transcriptional profiling at the exposure 
to 10mM Spm for 15 min, or 1mM Spm, 1mM Spd, 1mM Put, 2ng/μl Tetracycline (Tc) for 2h when 
indicated. cDNA was synthesized using VeriQuest SYBR Green One-Step qRT-PCR kit (Affymetrix). 
Specific primers for the genes tested and for gyrB (internal control) were designed using Primer 3 
software (Applied Biosystems) (Table S1). qRT-PCR was performed with the ABI 7500 Fast System and 
SYBR Green technology using cycling conditions of 10min at 50°C, 10 min at 95°C, followed by 45 
cycles of 15s at 95°C and 30s at 60°C. RT-PCRs were performed in a 50-μl reaction volume containing 
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1.5 μl of template RNA (10 ng/μl), 2.5 μl of gene-specific primers (9 μM), 25 μl of VeriQuest SYBR 
Green One-Step qRT-PCR Master Mix (2×), 0.5 μl VeriQuest RT enzyme mix (100×) and 18 μl of H2O. 
Each assay was performed in duplicate. The data analysis was carried out using 7500 system software 
(Applied Biosystems). Differences in Ct values between tested transcripts and gyrB signals were used for 
normalization purpose and based on the drug-free condition at 2h or 15min as reference. The fold change 
was expressed as the fold change of the difference between LB Ct (reference) and the stress condition Ct. 
PotR cloning, expression, and purification 
The full-length potR gene was amplified from genomic DNA of S. aureus Mu50 by using the primer pair: 
potR expr-F and potR expr-R in Table S1. The expression vector pBAD/HisD was first cut open by NcoI, 
and treated with Klenow fragment to fill recessed ends, followed by further digestion with EcoRI. The 
PCR product of potR was digested with EcoRI, and ligated to the pretreated pBAD/HisD. The resulting 
recombinant pPotR encoding the native form of PotR was further transformed into E. coli Top10 for 
overexpression. 
 
Native PotR was expressed after induction of a log-phase culture with 0.2% arabinose for 4h at 30°C. 
Cells were suspended in Q buffer (20mM Tris-Cl, pH7.6) containing Complete EDTA-free protease 
inhibitors (Roche), and disrupted by French press at 17,000Psi. After centrifugation at 20,000g × for 
30min, the supernatant was subjected to HiTrap Q HP column (GE) equilibrated with Q buffer. Following 
gradient elution with Q buffer containing 1M NaCl, fractions containing target protein were combined 
and desalted again with Aminco Ultra-4 centrifugal filter unit (Millipore) to change the buffer to 20mM 
Tris-Cl (pH 7.6). 
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Construction of a potRABCD knockout mutant 
DNA fragments corresponding to the upstream region of potR (arm1) and the downstream region of potD 
(arm2) were amplified with the primer pairs potR-arm1-F/potR-arm1-R and potD-arm1-F/potD-arm2-R 
(Table S1) by using the genomic DNA of S. aureus Mu50 as template. The PCR products were treated 
with BamHI/AvrII for arm1 and XhoI/BglII for arm2, respectively. Meanwhile, a 1.1-kb DNA fragment 
containing the kanamycin resistance gene aphA-3 was cut from pCN34 (16) by AvrII/XhoI. These purified 
DNA fragments were mixed with BamHI/XhoI digested pMAD-CM vector, and ligated with DNA ligase. 
The recombinant pMADCMΔpot::Km vector selected as blue colony which was able to grow on LB 
plates containing Amp (100μg/ml), Km (25μg/ml), and X-Gal. 
 
A two-step procedure was then used for allele replacement in S. aureus.  In the first step, the recombinant 
pMADCMΔpot::Km was introduced by electroporation into S. aureus strain RN4220. Transformants 
were selected after two days at 27°C on LB containing Em or Cm (10μg/ml) and X-Gal, and the 
antibiotic-resistant phenotypes of these transformants were confirmed in the same growth medium. 
Plasmid extracted from one such transformant was introduced into S. aureus strain HG003 by 
electroporation. Likewise, the obtained HG003/pMADCMΔpot::Km transformant was selected. In the 
second step, a single blue colony was cultivated at 27°C overnight in LB medium with Em or Cm 
(10μg/ml). Cultures from 27°C were inoculated into pre-warmed LB broth at 43°C without antibiotic at 
an OD600 of 0.1, and growth was continued for 4h at 43°C. Serial dilutions of this culture were plated on 
LB medium containing X-Gal and Km (50μg/ml) and incubated at 43°C overnight. The excision of the 
plasmid region in the chromosome by a double-crossover event was screened for Km-resistant, Em-
sensitive and white colonies, which nine candidate clones were obtained. To confirm the gene deletion, 
chromosomal DNA was extracted from three candidates and used in PCRs with primer pairs potA-del-
arm1 F/R or potD-del-arm1 F/R. No amplification of the region immediately downstream of potR or 
upstream of potD validated the authenticity of the null mutants.  
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Cloning of the speG and tetM genes 
The speG gene including its regulatory region (-516nt to speG translation initiation site and +53 nt to 
speG stop codon) from genomic DNA of S. aureus JE2 (USA300) was amplified by PCR, digested with 
BamHI-EcoRI and cloned into corresponding sites of pCN38. The resulting construct pCNspeG was 
confirmed by sequencing and introduced into S. aureus strain RN4220. Plasmid DNA isolated from 
recombinant strain of RN4220 was subsequently introduced into Mu50 by electroporation. The tetM 
structural gene as well as its upstream (-705nt with respect to tetM translation initiation site) and 
downstream (+668nt with respect to tetM stop codon) sequences was amplified from genomic DNA of S. 
aureus Mu50 by use of primer pair tetM del-arm1-F and tetM del-arm2-R. The PCR product was digested 
by BamHI and BglII, ligated with BamHI/CIAP treated pUC18, and screened by blue/white color 
selection. The obtained positive clone (blue) was confirmed by enzyme digestion and named as pUCtetM. 
Then tetM gene was cut out by BamHI/EcoRI with correct orientation from pUCtetM and subcloned into 
corresponding sites of E. coli-S. aureus shuttle vector pCN38. The construct pCNtetM was confirmed by 
sequencing, and introduced into S. aureus strain RN4220 by electroporation.   
Construction of promoter::GFP fusion for the pot operon 
Reporter strains were constructed using the putative promoter region of the pot operon. Primers potR-
arm1-F/PpotR-R were used for PpotR::gfp fusion, and potR-arm1-F/ potR-expr-R for PpotRA::gfp fusion, 
with genomic DNA from Mu50 as template. PpotR covers 836 bp extending from -790 nt upstream to 
+72 nt downstream of potR start codon. PpotRA covers 1304  bp extending from -790 nt upstream of 
potR start codon to stop codon of potR (-12 nt upstream of potA start codon). The PCR product was 
cloned in the BamHI-EcoRI sites with correct orientation upstream of a promoterless gfp gene of the 
shuttle vector pCN56 and was introduced into RN4220 by electroporation and subsequently into HG003. 
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Measurements of promoter activities 
Exponential growing bacteria carrying promoter::gfp fusion were grown in LB (pH 8.0) supplemented 
with or without 1mM polyamine (Spm, Spd or Put) with shaking at 37°C. After 2h, the cells were 
collected by centrifugation, and suspended into the same volume of Tris-Cl buffer (pH8.0). The green 
fluorescence was then measured with a spectrofluorometer (EnSpire® Multimode Plate Readers, 
PerkinElmer) by excitation at a wavelength of 485 nm and detection of emission at 515 nm, and the 
growth curve was monitored by measuring the OD600. The promoter activity value corresponds to relative 
fluorescence versus OD600. 
Electromobility shift assays 
A DNA fragment covering the regulatory region of potR (836 bp) was PCR amplified from 
pCNPpotR::gfp with primers pairs of oligonucleotide primers potR-arm1-F/PpotR-R. As a negative 
control, a DNA fragment of 510 bp covering the region of nt 704672-704162 on Mu50 chromosome was 
amplified with the following primers 704394-FP/RP (Table S1). For the binding reactions, the DNA 
probe at 7nM was allowed to interact with different concentrations of PotR in a mixture of 20 μl 
containing 150mM Tris-Cl (pH 7.5), 50mM NaCl, 1mM EDTA, 4mM dithiothreitol (DTT), 5% (vol/vol) 
glycerol, 3nM negative-control DNA, and 200 ng/μl acetylated bovine serum albumin. As specified, 
different polyamines at 20μM was added to the reaction mixtures. After incubation for 20 min at room 
temperature, 10 μl of each reaction mixture was loaded on a polyacrylamide gel (6%) in Tris-borate-
EDTA buffer (pH 8.7). The gels were stained with SYBR Green I solution (Invitrogen) for 20 min, 
washed twice with deionized H2O, and scanned with an imaging system (Omega UltraLum) with a setting 
for excitation at 473 nm and emission at 520 nm. 
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Polyamine Uptake 
Radio-labeled polyamines were used for uptake assays as previously describe with slight modification. 
Cultures of S. aureus strain JE2 (wt) and its potD mutant (NE658) were grown in LB broth (pH8.0) to 
mid log-phase before harvest. The cell pellets were washed twice with 50mM Tris-HCl, 50mM NaCl, pH 
7.5, and resuspended at a concentration of cell number approximate 1x109 (OD600 = 1) in the same buffer, 
followed by the addition of chloramphenicol (final conc.250ug/ml). After incubation of the cell 
suspension for 5min in 37°C water bath, different polyamines (14C Spm, 3H Spd, 3H Put) was added to a 
final concentration of 500 uM, and samples (80ul) were withdrawn at various time intervals.  Cells were 
collected on a cellulose membrane filter (0.22 um pore size, type GS, Millipore) and washed with 5ml of 
above buffer. Membranes were air dried in clean scintillation vials. Incorporated radioactivity was 
measured using 2ml of scintillation liquid and spectrometer (Beckman). Specific activity of radioactive 
polyamine: 14C Spm, 0.1Ci/mmol; 3H Spd, 44.5Ci/mmol; 3H Put, 33.6Ci/mmol. 
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Figure 5. 1 Binding of polyamines to DNA. 
Equal amounts of a DNA fragment were mixed without or with the indicated conc. of polyamines before 
electrophoresis. Interactions of polyamine and DNA results in the reduced intensity of DNA fragments 
 
 
 
 
 
Table 5. 2 MICs of Spm and Ox in speG supplementing Mu50. 
                          
                         Mu50/speG, S. aureus strain Mu50 harboring pCNspeG 
 
 
 
 
 
Spm SpdPut
Spm MIC
(mM)
Oxa MIC (ng/μl)
No 
Spm
0.5mM 
Spm
8mM 
Spm
Mu50 2 256 2 NA
Mu50/speG 64 256 256 2
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Figure 5. 2 FIC isobologram for combinations of Spm and Ox against S.aureus Mu50. 
The FICs were determined by checkerboard assay. 
The additive line is drawn in dotted line. FICindex was shown in bracket.  
 
 
                                      
Figure 5. 3 Inhibition of growth by spermine and spermine/oxacillin combination. 
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5.3 RESULTS 
Binding activity of Spm to DNA 
The character of positive charges carried by polyamines, especially Spm and Spd, has long been 
considered possessing adverse effects if these essential compounds were accumulated to high 
concentrations inside the cell. To demonstrate the potential toxicity of polyamines by their charge 
interactions with nucleic acid polymers, we tested the DNA-binding activity of Spm, Spd, and Put in vitro. 
When bound to DNA, polyamines are expected to reduce overall net negative charges of DNA-polyamine 
complexes, thereby affecting the mobility of these complexes on the native PAGE. In other words, 
formation of these complexes would be reflected on decreased amounts of free-form DNA. As shown in 
Figure 5.1, the intrinsic DNA-binding affinity of Spm is about 10-fold higher than that of Spd, and no 
apparent binding by Put can be detected even at the concentration of 5mM. This trend of DNA affinity 
(Spm > Spd > Put) is consistent to that of toxicity of polyamine (7), suggesting the charge interaction 
(referred to the first mode of Spm action, as described in General Introduction and Figure 1.2) is at least 
partially responsible for the Spm toxicity in S. aureus.  
Acetyltransferase SpeG affects Spm toxicity but not Spm/β-lactam synergy  
Unlike P. aeruginosa, most strains of S. aureus cannot grow on Spm. However, one recent report 
identified the existence of a polyamine acetyltransferase (SpeG) present only in certain strain lineages 
(e.g. USA300 of SCCmec IV group) (48). The speG gene encoded within the ACME (arginine catabolic 
mobile element) island of USA300 group exhibited significant homology to SpeG from E. coli, and was 
necessary and sufficient for Spm resistance. Our data present in Table 5.2 also showed that expressing 
speG in trans in non-USA300 strains (Mu50 and RN4220) granted the complete resistance to these Spm-
sensitive bacteria, supporting the existence of Spm-dependent cytotoxic effect on an intracellular target.  
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Besides toxicity per se, exogenous Spm also exerts particular effect on the sensitization of MRSA to β-
lactams as characterized in Chapter 2. To examine the role of SpeG on Spm/β-lactam synergy, the 
checkerboard analysis was conducted in Mu50 and its speG-transformant. The FIC index of Spm/Ox 
clearly showed strong synergy in both strains (Figure 5.2).  However, it needed at least 8 mM Spm to 
exert noticeable synergy on Mu50 harboring a recombinant clone of speG, while a much lower dose of 
Spm (0.5 mM) was sufficient to cause the same effect on the native Mu50 without speG (Table 5.2). 
These results support the hypothesis that the molecular target(s) of Spm toxicity and synergy with β-
lactams may reside inside the cells. 
Transcriptome analysis of S. aureus in response to high dose Spm 
To investigate the changes in transcriptome profiles in response to high dose Spm, we conducted a series 
of independent microarray experiments in the absence (control group) and the presence (experimental 
group) of 10mM Spm upon 15, 30, and 60 min exposures (Figure 5.3). To further identify genes with 
statistically marked changes in expression levels, we applied the following criteria to each of the control-
experimental microarray data sets: (1) p value ≤0.05, (2) absolute fold change in transcript level ≥2.5, and 
(3) for up-regulation, gene in experimental group has a presence of ≥200 signal intensity; for down-
regulation sorting, gene in control group has a presence of ≥200 signal intensity. Of the over 3000 ORFs 
in the genome of S. aureus, a list of 581 genes showing significant changes upon Spm treatment was 
compiled with this approach. To examine how these genes were distributed with regard to their 
physiological and biochemical functions, they were further classified according to COG functional 
categories (Figure 5.4). Transcriptional profiles of representative genes were shown in Figure 5.5, and 
below described some of the major findings. 
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Figure 5. 4 Biological processes that are regulated in response to high dose spermine (>2.5 fold). 
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1) Up-regulation 
Iron uptake and metal-dependent repressor 
A number of genes encoding metal transporters (especially for iron) showed increased expression, 
indicative of possible dysregulation of metal homeostasis by Spm challenge. S. aureus acquires iron 
through siderophore or heme. It has been reported that FhuABGD (ferric hydroxymate uptake), HtsABC 
(heme transport system), and SirABC (staphylococcal iron regulated transporter) participate in 
siderophore import, while heme uptake go through Isd system and HtsBC permease. In specific, for 
siderophores import, staphyloferrin A is mediated by HtsABC and FhuA, staphyloferrin B by SirABC 
and FhuA, while xeno-siderophore by FhuABGD; Isd systems and HtsBC are responsible for heme 
acquisition (35). Here, the fhuABG, htsABC, isdF all showed 3-6 fold up-regulation by Spm.  In addition, 
the norA gene encoding an iron-responsive efflux pump in S. aureus (28), also displayed over 2.5- fold 
increase. Moreover, four major metal-mediated repressors, Fur, PerR, Zur (three Fur family members) (41, 
42, 64, 69) and MntR (DtxR-like protein)(43), all displayed induced expression.  Although varying in 
DNA binding sites and dependence on metal ions, these repressors share a similar mode of action: metal 
binding to the regulators leads to homodimeric binding to a concensus sequence that overlaps the 
promoters of genes under its direct control, resulting in gene repression. In specific, upon iron limitation, 
dissociation of F2+-Fur complex derepresses Fur regulon and activates genes in siderophore synthesis, 
transport, and regulation (fur itself)(27). Meanwhile, PerR, Zur or MntR also can directly or indirectly 
modulate the Fur regulon, expanding the regulatory capability on iron uptake and storage. In addition to 
iron-dependence, the PerR regulon (including fur and perR itself) also can be activated by peroxide, for 
modulation of oxidative stress resistance (41).  Collectively, these observations revealed a complex 
regulatory network in S. aureus to maintain homeostasis of iron and other metal ions, which responds to 
possible signals of iron-restricted stress imposed by Spm toxicity. 
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Regulation of osmotic balance 
Some Spm-induced genes likely contributed to osmotolerance, such as those encoding glycine betaine 
transporter (opuD), choline dehydrogenase (betA), glycine betaine/carnitine/choline ABC transporter 
operon (opuCA/CB/CD), and glycine aldehyde dehydrogenase (gbsA). Of interest, the kdpABC operon for 
an ABC transporter and kdpDE for a two-component regulatory system of potassium uptake were also 
induced significantly under Spm stress. 
  
Amino acid metabolism and transport  
Genes related to amino acid metabolism and transport, particularly those for arginine and urease 
biosynthesis, showed significant induction. Up-regulation of these amino acid synthetic pathways, despite 
being high consumers of ATP, infers an increased need of specific amino acids during the Spm stress. 
Another notable finding was the induction of an ABC transporter-the putative polyamine uptake system 
potABCD. Investigation of this operon is described below. 
 
DNA repair or/and recombination  
Some transcripts up-regulated by Spm were coding for enzymes involved in DNA repair or/and 
recombination, namely, uvrC, nucC, xerD, dinB, holA, etc. However, recA and lexA, two signature genes 
of standard SOS response (3), were not included in the list. It indicated that the Spm stress is different 
from most DNA-damaging agents, and may not trigger the SOS response.   
 
2) Down-regulation 
ATP synthesis and carbohydrate metabolism/transport 
The addition of Spm to S. aurues decreased the expression of genes in major energy-providing central 
metabolic pathways to different extent, including fermentation, glycolysis, gluconeogenesis, pyruvate 
conversion, pentose phosphate cycle, and TCA cycle. We also noticed a down-regulation of the 
membrane-bound ATP synthases (F0F1-ATPases) which catalyze the synthesis of ATP by utilizing the 
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energy of an electrochemical gradient of protons. These data indicate an overall decreased activity or 
demand of energy production during Spm treatment.  
 
Many genes in carbohydrate metabolism and transport were down regulated. In specific, expression of 
ptsIH for glucose uptake(93) was decreased, consistent with the reduction of glycolysis and pentose 
phosphate cycle (the alternative glucose degradation pathway), as described above.  Moreover, expression 
of the lacABCDFEG operon for lactose utilization was also decreased. The assimilation of lactose or 
galactose by S. aureus accumulates galactose 6-phosphate. This phosphorylated carbohydrate is the actual 
intracellular signal molecule for induction of the lactose (lac) genes, which can be further metabolized to 
triose phosphates used in the glycolysis (72). Taken together, reduced expression of genes for sugar 
uptake and utilization was consistent with the pattern of down-regulation in ATP synthesis.  
 
The SigB regulon 
One very striking event upon Spm stress was the down-regulation of Sigma B (SigB, σB) regulon. A total 
of 251 genes was reported in the σB regulon of S. aureus (12), and 96 genes of this regulon were found 
responsive to high dose Spm. However, among these genes 79 ORFs positively controlled by σB exhibited 
reduced expression while 17 genes which are repressed by σB display an upregulated pattern in response 
to Spm stress (Figure S4, Figure 5.5).   
 
The alternative sigma factor σB of S. aureus is in charge of the general stress response, expression of 
virulence determinants, and modulation of antibiotic resistance. It controls a large regulon, either by 
directly recognizing conserved σB promoter sequences (e.g. asp23, clpL) or indirectly via σB-dependent 
elements (e.g. RNAIII, agrA) (78, 101). In specific, σB has been shown to influence the expression of 
several global regulators, including up-regulation of SarA, SarS (SarH1) as well as down-regulation of 
RNAIII and agr regulatory system, all of which showed altered pattern in our study. Of note, the function 
of σB in virulence factor production is exactly the opposite from that of RNAIII/agr quorum sensing 
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circulars (the latter negatively regulates adhesins and positively regulates exoenzyme and toxins 
production). Therefore, the increased expression of exoprotein and toxin transcripts under Spm stress 
might be a consequence of lower σB and/or higher RNA III transcription.  
 
From the results of transcriptome analysis, it was very clear that the σB regulon was turned off under Spm 
stress. Conserved in most bacteria, the major physiological function of the σB regulon was to protect the 
cells when under stress. However, it was surprising that Spm stress in fact shuts down the σB regulon. We 
consider this effect could be very detrimental to the cells. This novel finding warrants future investigation 
on the molecular mechanism of Spm effects on σB.   
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Figure 5. 5 Transcription profiles of representative genes influenced by high dose spermine. 
Transcript levels sampled at different time points of growth (x axes). Data points were plotted as relative 
intensity value (y axes). Red line, up-regulation by Spm; blue line, down-regulation by Spm; gray line, no 
Spm treatment. Candidates genes were categorized according to functional class.  
  
SigB regulon
• σB positively controlled genes 
were down-regulated  by Spm
• σB negatively controlled genes 
were up-regulated  by Spm
DOWN by Spm
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Among genes that were induced by 10mM Spm, the tetM gene for tetracycline resistance, the putative 
potRABCD operon for polyamine uptake and regulation, as well as the divergent kdpFABCD-kdpDE 
operons for a potassium uptake channel and regulation exhibited most significant fold change and high 
signals as confirmed by qRT-PCR. These genes were subjected to further characterization to gain insights 
into their potential roles in Spm toxicity and/or resistance mechanisms.  
Spermine-specific induction of tetM  
The tetM gene encodes a protein that confers resistance to tetracycline (Tc) by interacting with the 
ribosome and promoting the release of bound Tc from the ribosome (20, 107). This gene is found 
primarily, but not exclusively, in the Firmicutes and is known to be carried mostly by conjugative 
transposons of the Tn916 family(96). In S. aurerus Mu50, tetM was identified on Tn5801(59), which 
contains highly conserved ORFs in four functional modules: conjugation, regulation, recombination and 
accessory genes such as tetM(24).  
 
As revealed by transcriptome analyses (Table S3,S4) and further confirmed by qRT-PCR (Figure 5.6), 
tetM in Mu50 was highly induced by both high dose and low dose Spm, It is of interest to understand why 
Spm can induce tetM transcription and whether the expression of TetM is able to confer resistant to Spm.  
 
First, to test whether the TetM is indeed responsible for Tc resistance, the tetM gene including its 
regulatory region from Mu50 was cloned and transformed into E. coli (DH5α) as well as S. aureus strains 
(RN4220) where tetM was absent. In the subsequent drug-susceptibility test, MIC of Tc in RN4220 
harboring tetM increased more than 30- fold in comparison to its host, equivalent to that in Mu50; 
similarly, tetM was able to raise the tolerance of E. coli to Tc, but to a less extent (Table 5.3).  
 
Since Spm toxicity also applies to strains of S. aureus without the tetM gene, it is unlikely that TetM is 
the molecular target of Spm toxicity. However, it was possible that TetM expression might promote Spm 
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resistance. To test this hypothesis, Spm MIC was determined in S. aureus strains carrying plasmid-borne 
tetM in contrast to their individual hosts. In particular, cells grown in 1/8 MIC of Tc (able to stimulate 
TetM synthesis whereas not affecting bacterial growth) were used as positive control. As revealed by 
Table 5.3, both RN4220 and Mu50 showed no differences on the Spm sensitivity regardless of tetM 
expression, indicating the up-regulation of tetM by Spm is not a defensive mechanism to Spm toxicity.  
  
Next, the response of tetM to different polyamines was investigated. Exponential growing cells of Mu50 
were exposed to various polyamines (Spm, Spd, and Put; 1 mM), and the culture with low dose Tc 
(2ng/µl) served as positive control of tetM induction. Transcript levels were analyzed by qRT-PCR in 
comparison to that of the untreated sample. As shown in Figure 5.6, tetM expression was specifically 
induced by Spm and Tc to a comparable level but not by Spd or Put.  Although tetM may not play any 
role in Spm toxicity, the molecular mechanism of tetM induction by Spm and its potential role in Tc 
resistance is exceptionally interesting and warrants further investigation in the future. 
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Table 5. 3 MICs of Tc and Spm  in tetM-supplementing bacteria. 
 
RN4220/tetM, S. aureus strain RN4220 harboring pCNtetM 
DH5α/tetM, E. coli strain DH5α harboring pCNtetM 
Cells were pre-grown in 1/8 MIC of Tc prior to Spm MIC measurement. * ND, not determined. 
 
 
 
  
 
 
Figure 5. 6 RT-PCR analysis of tetM in response to different polyamines. 
The fold change represents the difference between Ct of drug-free condition (reference) 
and Ct of the compound-supplement condition. 
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The potRABCD locus for polyamine uptake and regulation 
As revealed from the transcriptome on exposure to high dose Spm (Figure 5.5, Table S3, S4) and qRT-
PCR validation (Figure 5.8), the potABCD genes for a putative polyamine transport system were highly 
induced by high dose Spm but not by low dose Spm. Although PotABCD share high sequence similarities 
to the E. coli counterparts (Figure 5.7) preferential for Spd uptake(46), information about the regulation 
and the physiological function of this system in S. aureus was mainly unknown.  
 
The pot operon in S. aureus is composed of five genes, with PotA an ATPase, PotBC channel forming 
unit, PotD a substrate-binding protein, as well as PotR a putative transcriptional regulator (SAV1098 in 
Mu50) immediately upstream of potABCD which is absent in the pot loci  of E. coli (45) and most other 
bacteria.   
 
First we measured pot expression in the absence and presence of three different polyamines (Spm, Spd, 
and Put). Exponentially growing cells of Mu50 were exposed to low dose polyamines (1mM) for 2 hours 
and the transcript levels of potA were determined by qRT-PCR. As shown in Figure 5.8, both Spd and Put 
induced potA expression by 3-fold and 2.4-fold, respectively, whereas low dose Spm showed little effect.  
 
Next, kinetic measurements of polyamine uptake were conducted in the parental strain JE2 and its potD 
mutant NE658 as described in Materials and Methods. As shown in Figure 5.9, uptake of 3H-Spd or 3H-
Put by JE2 increased linearly from 0 to 8 min while no apparent uptake of Spm can be observed. 
Meanwhile, uptake of Spd and Put was abolished in the potD mutant. These results from uptake 
measurements and qRT-PCR as described above support PotABCD as the major transport system for Spd 
and Put in S. aureus. In addition, these results did not support the presence of any active or high-affinity 
Spm uptake system. The lack of an active Spm uptake system may be advantageous for most strains of    
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S. aureus that do not possess SpeG or other Spm modification enzymes as an alternative mechanism to 
fence off Spm toxicity. 
 
However, it's important to note that in contrast to low Spm, high dose Spm does have the ability to induce 
pot expression (Figure 5.8). Although the uptake experiments were not conducted with high Spm as 
substrate, the fact that plasmid-borne speG does protect the cells from Spm toxicity (Table 5.2) supports 
that Spm is indeed taken into the cytoplasm by unknown transporter(s).  
 
To determine whether the potRABCD operon has any effect on Spm sensitivity or synergy, drug 
susceptibility assay was conducted in parental strain HG003 and its pot deletion mutant (HGΔpot::Km). 
As shown in Table 5.4, Spm MIC in the pot mutant was comparable to that of HG003; likewise, the lack 
of pot also had no influence on the Spm/β-lactam synergy. These results were consistent to the conclusion 
that the PotABCD system is not the major transporter for Spm in S. aureus. 
 
Another interesting feature for the pot operon is the gene which resides immediately upstream of potA, 
named as potR (SAV1098 of Mu50) in this study (Figure 5.7A).  PotR belongs to the Cro/Cl family of 
transcriptional regulators. Unlike in E. coli and many other human pathogens of which the potABCD are 
organized as a four-gene operon, the presence of potR within the pot cluster in S. aureus is suggestive of 
its role in modulating polyamine homeostasis. To determine the possible regulatory role of PotR on pot 
operon, two transcriptional promoter fusions were designed: 1) PpotR covering a 836-bp intergenic region 
upstream of potR; 2) PpotRA including the intact potR and its upstream intergenic region. These 
recombinant plasmids carry gfp as reporter gene, and the resulting pCNPpotR::gfp and pCNPpotRA::gfp 
were introduced into S. aureus HG003. The recombinant strains were grown in plain LB (pH 8.0), and the 
promoter activities were measured by relative fluorescence of GFP versus OD600. As shown in Figure 
5.10, the promoter activity in PpotR was on average 10-fold higher than that of PpotRA, suggesting the 
potential role of PotR (carried by PpotRA but not by PpotR) as a repressor in regulating the pot promoter.  
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In order to examine how PotR could possibly regulate pot operon in response to polyamines, the promoter 
activities were determined in strain HG003 carrying PpotRA grown in the presence or absence of 1 mM 
Spm, Spd, or Put. Unexpectedly, none of the polyamine supplements can affect the promoter activity 
(Figure 5.10).  However, the lack of regulation by polyamines in this promoter construct could be due to 
the nature of the vector plasmid. We have later found that because of unknown reasons even the tetM 
promoter was much less responsive to the presence of tetracycline when cloned into this vector (data not 
shown).   
 
The DNA-binding activity of PotR was also tested in vitro. PotR was purified to homogeneity as 
described in Materials and Methods, and subjected to electrophoresis mobility shift assays (EMSA) using 
PpotR as probe. As shown in Figure 5.11, formation was a PotR-dependent nucleoprotein complex 
demonstrated specific binding of PotR to the probe. When tested for effect of polyamines on PotR-DNA 
interactions, no apparent effect on the DNA-binding activity was detected. 
 
  
90 
  
 
 
 
                 
Figure 5. 7  Schematic representations of Pot system. 
(A) Organization of pot loci and neighboring regions in S.aureus Mu50.  
Arrows indicate fragment upstream of potR (PpotR) or potA (PpotRA) for promoter fusion.    
(B) Schematic of PotABCD structure and regulation in E.coli 
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Figure 5. 8 RT-PCR analysis of potA in response to different polyamines. 
The fold change represents difference between Ct of drug-free condition (reference) and Ct of the 
compound-supplement condition. 
 
 
 
 
Figure 5. 9 Uptake of different polyamines in wild type  and potD mutant 
w.t. JE2; ∆potD, NE658. Cells grown in plain LB medium (w/o polyamine) were collected and subjected 
to uptake assay with radiolabeled polyamine. 
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Table 5. 4 MICs of Spm and CFZ in wild type and pot mutant. 
 
w.t, wildtype, S. aureus strain HG003;  
HGΔpot::Km, pot operon null mutant of HG003 
 
 
 
 
Figure 5. 10 Promoter activity of PpotR or PpotRA. 
S. aureus strain HG003 harboring pCNPpotR::gfp or pCNPpotRA::gfp was grown for 2h in the presence 
or absence of polyamine. Promoter fragments are indicated as in Figure 5.7A. The promoter activities 
were expressed as relative fluorescence versus OD600 of the culture. Standard deviations are derived from 
at least two independent cultures.  
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Figure 5. 11 Electromobility shift analysis of PotR-Ppot interaction. 
The assays were conducted in the absence of polyamines, or the presence of 10μM polyamine (Put, Spd, 
or Spm).  F, free probe; N, negative control DNA; C, PotR-DNA complex 
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The kdpFABCDE locus 
The kdp genes for potassium uptake and regulation are widely distributed among bacteria (29)  (Figure 
5.12). In E. coli, the KdpABC is a high-affinity K+ uptake ATPase, and its expression is regulated by the 
KdpDE two-component system in response to K+ limitation or turgor pressure. This K+ transporting 
ATPase shares high sequence similarities with the K+ channel in eukaryotes (47). Given the report that 
Spm could enter and occlude the central K+-channel pore (102, 117), we proposed that in S. aureus Spm 
may block the K+ uptake in the same manner, and therefore supplement with high concentration of K+ 
may increase Spm resistance by counteracting Spm obstruction on this potassium channel. Spm MIC in 
Mu50 was measured in LB containing 300 mM KCl. As shown in Table 5.5, KCl addition can cause 32-
fold increment on Spm MIC. 
 
Aside from K+ limitation, it has been proposed that turgor loss (high osmolarity) serves as the regulatory 
signal for the kdp operon(8). To test whether the induction of kdp by Spm was due to osmolarity upshift, 
we also measured the Spm MIC in the presence of other osmotic-shock agents, 300mM NaCl and 600mM 
sucrose (Table 5.5). Surprisingly, like KCl, NaCl also enhanced the tolerance of Mu50 to Spm; 
nonetheless, osmotic shock with 600mM sucrose showed no effect. While these results support possible 
relationships between Spm and osmolarity, more work will be needed to understand induction of the kdp 
operon by Spm. Recently, kdpDE in S. aureus was reported up-regulated by the Agr/RNAIII system (118), 
which is consistent with our observation of highly induced agr/RNAIII by Spm, suggesting the role of 
Spm in regulating virulence with the potential coordination between K+ sensing and Agr signaling in S. 
aureus. 
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Figure 5. 12 Schematic representation of Kdp system. 
 (A) Organization of kdpFABCDE in S. aureus and E. coli. 
Identity and similarity scores correspond to similarities between the protein sequences.  
(B) Schematic of KdpFABCDE structure and regulation in E. coli 
 
 
 
 
 
ND, not determined 
kdpC
kdpB kdpA
kdpD
kdpE
ATPase TCS
kdpF*
kdpC kdpB kdpA
kdpF
kdpDkdpE
S. aurues
E. coli
Identity
(%)
Similarity 
(%)
KdpF 48 67
KdpA 43 60
KdpB 55 72
KdpC 37 58
KdpD 26 49
KdpE 39 61
J. Biosci. 32(3), April 2007
 i
None 300mM KCl
300mM
NaCl
600mM 
Sucrose
Spm(mM) 1 32 16 1
Oxa
(ng/μl)
No spm 512 512 ND ND
¼ MIC spm 1 512 ND ND
A 
B 
E. coli 
Table 5. 5 Effects of osmotic-shock solutions on the MICs of Spm and Ox in Mu50. 
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5.4 DISCUSSION 
Transcriptome analysis  
In Chapter 4 and 5, we have analyzed changes in the transcriptome of S. aureus Mu50 upon Spm stress 
and Spm/Ox synergy. Overall, 581 genes were identified responsive to Spm while 408 regulated by 
Spm/Ox. Those genes of interest were placed into functional groups to define high dose Spm-dependent 
regulation as well as low dose Spm/Ox-affected profiles. 
 
The stimulation of iron acquisition genes (including iron uptake and metal-specific regulators) was 
particularly of note. The induction was moderate under low dose Spm (fhuABG 2-3 fold, htsABC 6- fold, 
regulators 1.5-fold), and further magnified upon Spm/Ox combination (fhuABG 4-fold, htsABC 12- fold, 
regulators 3.5- fold). Interestingly, high dose Spm increased iron related expression to similar levels as 
those by Spm/Ox synergy (fhuABG 3.5-4 fold, htsABC 4- fold, regulator 3-4 fold) (Figure S3, S4) 
 
As known, iron is essential for bacteria due to its involvement in multiple metabolic processes, including 
respiration (heme-containing cytochromes, [Fe-S]-containing ferredoxins) and key enzymes in central 
metabolism ([Fe-S]-containing enzymes in TCA, like SdhA, CitB, CitG) (34, 35). However on the other 
hand, iron can also become hazardous due to the Fe2+ -triggered Fenton reaction which produces harmful 
ROS (21). Therefore, there is significant regulatory crosstalk between iron homeostasis and oxidative-
stress resistance networks.    
 
Collectively, we propose a model for Spm toxicity and Spm/β-lactam synergy as described below. Based 
on the transcriptome analysis, it seems Spm may generate iron-deplete conditions or change the 
intracellular iron status by some yet-unknown mechanisms. Such iron starvation signals are sensed by 
metal-specific regulators (Fur, PerR, MntR, Zur), which initiate derepression of iron uptake systems. The 
incorporation of internalized iron into iron-proteins may not catch up with the burst of Fe2+ within the cell, 
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which therefore, would promote Fenton reaction and ROS buildup. Even though low dose Spm is 
sufficient to induce iron uptake, the delivered impact may be sequestered by redirecting central 
metabolism, thus explaining why low dose Spm has no inhibition on S. aureus. Upon high dose Spm, the 
potential detrimental effect resulting from a flood of iron input might be overwhelming, which leads to 
the instant inhibition on cell growth. Furthermore, the fact that high dose Spm is able to turn off the SigB 
regulon may cause the cells even more stress to survive. Under Spm/Ox synergy, stimulation of the of 
H2O2 production by β-lactam (54) might be compounded with increased Fe2+ by Spm to produce a high 
level of deleterious hydroxyl radicals, and thereby inducing cellular death. 
Spm, iron (heme) and electron-transport/energy production 
A recent report shows that Spm toxicity may rely on the biosynthesis of menaquinine (48), the only 
electron carrier in S. aureus. This implies the essentiality of electron-transport during the Spm effect. Of 
note, as the other essential factor in electron-transport for the biosynthesis of cytochromes, heme and the 
associated iron-acquisition genes, showed significant induction under Spm stress, inferring a correlation 
between heme/iron and Spm. Therefore, both heme and menaquinine, two indispensable components for 
electron transport chain, seem to have connections with Spm, which indicates the possible effect of Spm 
on cellular respiration and energy production.  In fact, the down-regulation of genes in the glycolytic 
pathway and the TCA cycle which require electron-transport chain to generate ATP, as shown in the 
transcriptomic profiles, also suggests the need of iron/heme upon Spm exposure may come from the 
respiration defect.  
tetM 
Tetracycline (Tc) functions by binding to the helix 34 and helix 31 in the 16s rRNA of 30S ribosomal 
subunit and preventing aminoacyl-tARNA(aa-tRNA) access in to ribosomal A site (20). The ribosomal 
protection protein TetM can release Tc binding and rescue the ribosome to return to the elongation 
cycle(106).  The mechanism for tetM regulation has been proposed through transcriptional attenuation 
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(105). A ‘leader peptide’ immediately upstream of tetM, contains rare amino acids; therefore, the 
ribosome pauses at these positions due to the shortage of rare aminoacyl-tRNAs (aa-tRNAs), leading to 
retarded translation. The non-synchronism of RNA polymerase and ribosome makes the transcription 
terminated at the stem-loop termination sites which are upstream of tetM start codon, resulting in no 
expression of tetM when Tc is absent. When cells are exposed to Tc which retards the translation, there is 
a backup of charted tRNAs, including the rare ones needs within leader peptide. The increased 
availability of these aa-tRNAs allows coupled translation and transcription, thus able to disrupt step-loop 
terminator. Transcription then proceeds into tetM, and more TetM were expressed to protect ribosome 
from Tc attack.  
 
Spm was previously reported able to bind with 16S rRNA in ribosomal 30S subunit (1). The 5’ domain, 
the internal and terminal loop of helix h24 as well as the upper part of h44 in 16sRNA (partially overlap 
with some Tc binding sites), were found as preferable binding sites for Spm. The effects of Spm 
interactions with 30S subunits on ribosomal functions were further characterized in many aspects: 1) Spm 
can enhance the binding of aa-tRNA to the A site to ribosome; 2). Spm cross-linking to rRNA reduces the 
translational accuracy and therefore increases the probability of using ‘wrong aa-tRNA’ for translation in 
the lack of right cognate aa-tRNA; 3) Spm had no impact on the peptide bond formation (1). Based on 
these, along with the transcriptional attenuation model for Tc regulation on tetM, it was reasonable to 
propose that a) Spm may behave like Tc by inhibiting translation to induce tetM; or b) Spm may facilitate 
aa-tRNA incorporation to 30S binding site thus bypass the transcriptional attenuation of tetM and enhance 
its expression. Considering the fact that Spm does not restrain the aa-tRNA binding as mentioned above, 
the former mechanism is less favorable. 
How does S. aureus protect itself from Spm toxicity? 
From this study we concluded that one way S. aureus protects itself from Spm toxicity is to avoid Spm 
uptake. We demonstrated the absence of active Spm uptake in Mu50. Although the potABCD operon for a 
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polyamine uptake system is induced by high dose Spm, several lines of evidence exclude its role in Spm 
uptake. However, S. aureus is still vulnerable to exogenous Spm, indicating Spm uptake through 
unknown channels. Another protection mechanism against Spm toxicity is to recruit Spm modification 
enzymes. Introduction of speG encoding a spermine acetyltransferase into Mu50 indeed rendered the 
recombinant strain resistant to high dose Spm. The presence of speG in USA300 and other strains in this 
lineage may be able to provide growth advantage for these strains in hosts that synthesize and release 
Spm in blood and tissue fluids.  
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CHAPTER 6: GENERAL CONCLUSION 
Polyamines are ubiquitous polycationic molecules synthesized by and required for all life.  Putrescine and 
spermidine are distributed widely in all living organisms, but spermine is primarily present in eukaryotes 
(and many thermophilic bacteria). The distinct distribution of this tetra-amine suggests that Spm may 
associate with some new activities or specific regulations during evolution. Of interest, increased Spm 
levels have been demonstrated at inflammatory sites of infection and in cancer cells, suggesting the 
significance of Spm in cell proliferation and immune functions in human body. In contrast, many studies 
showed that exogenous Spm may become toxic to bacteria with accumulation, the inhibition of which is 
especially strong in S. aureus.  Moreover, we also found that at low concentrations, Spm by itself has 
negligible effects while is able to sensitize β-lactam antibiotics to kill bacteria; such synergy is most 
potent in S. aureus. In this study, we explored the targets of Spm toxicity and its synergy with β-lactams 
and provided insights into how Spm could possibly work alone or in combination with β-lactams to exert 
the antibacterial activities. 
 
Spm toxicity 
Owing to the positive charges at physiologic pH, Spm effects have been implicated through electrostatic 
interactions with anionic molecules (e.g. DNA/RNA). However, our pH dependent profiles revealed that 
the Spm-dependent inhibitory effects (both alone or with β-lactams) are effective at higher pH (≥8); in 
addition, the acetylated Spm had no effect on the growth of S. aureus, further supporting the notion that 
toxicity may not be correlated with net positive charge since both nontoxic acetyl-Spm and toxic Spd 
have the same net + 3 charge. Based on our two mode action model, the effects of Spm in bacteria may 
largely result from its nucleophilic activity of free amines at higher pH.   
In general, Spm toxicity can be reduced by increasing Spm catabolic activity or blocking Spm uptake. 
Unlike in P.aeruginosa which can use Spm as carbon/nitrogen source through GPS, most S. aureus 
strains do not have Spm catabolic genes except the USA300 lineage. By acquiring a SSAT SpeG, those 
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strains can modify Spm through acetylation and remove its toxicity. For the uptake, S. aureus has a 
putative polyamine transport system potABCD, while deletion of which cannot confer resistance to Spm. 
This suggests the putative Pot transporter may not be the major Spm uptake system in S. aureus.  
 
Spm/β-lactam synergy 
Another effect of Spm on bacteria is to sensitize MRSA to β-lactam antibiotics. In theory, Spm/β-lactam 
synergy can be achieved through two possible mechanisms: 1) Spm may have the same primary target as 
β -lactams by attacking the cell wall; 2) Spm toxicity can be amplified by side effects of β-lactams to 
achieve the synergistic killing.  In our study, although a spontaneous Spm-resistant mutant of MRSA 
containing a defected PBP2 can confer resistance to the synergy, the transcriptome and PBPs analyses in 
wildtype show that: Spm neither suppresses the expression of PBPs or other members in the cell-wall 
stress stimulon, nor affects the binding affinity of PBPs to β-lactams. It suggests that Spm may not have 
the same primary target as β-lactams. In contrast, Spm induces a number of genes for iron acquisition 
while reducing energy-producing pathways and the SigB regulon, which are remarkably distinct from β-
lactam triggered profiles. More importantly, those genes also showed a similar regulated pattern under 
Spm/ β-lactam combinational condition; in other words, the synergy-responsive genes overlapped 
extensively with those to high Spm challenge. 
 
Therefore, we contend that the Spm effects may be amplified during the synergy, via two possible 
mechanisms: 1) the side effect of β-lactam (e.g. production of ROS) may react with Spm triggered 
compounds to form some strong killing factor; 2) the side effects of β-lactam may share the same target 
of Spm, thus enhancing the Spm toxicity. Such hypothesis could also explain why the PBP2 deficient 
mutant became resistant to Spm/ β-lactam syerngy: w/o TPase domain in PBP2, β-lactams lose their 
primary target and are unable to engender any side effect; thus, moderate concentration of Spm by itself 
cannot elicit intense toxicity to bacteria, which makes the mutant able to survive under Spm/ β-lactam 
condition. 
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Collectively, our study indicates the role of Spm could be multifarious with more than one target, and a 
combination of Spm and β-lactams may inhibit growth of MRSA in a more complicated manner than just 
potentiating β-lactam inhibition on PBPs. 
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APPENDICES 
APPENDIX A: SUPPLEMENTARY DATA 
                     
                            
                                                                              
       
  Oligonucleotide Sequence Application 
PBP1-expr-noTM-F  AAAACTGCAGCATGATTACTGGACATTCTAATGG   
construction of pBAD/HisD expressing His-PBP1 
PBP1-expr-R CCGGAATTCGTTAGTCCGACTTATCCTTGTCAG       
PBP2-hisC59 -F      GCCC TCATG AGG AAAGCACCTGCTTTTACCGAAGC 
construction of pBAD/HisE expressing His-PBP2 
PBP2-hisC716-R       TCC CCCGGG AGATTGTTGAGATCTAGTATTGTTATTTG 
PBP3-expr-noTM-F  AAAACTGCAGACAAATCGCACAAGGCTCACATTA  
construction of pBAD/HisD expressing His-PBP3 
PBP3-expr-R     CCGGAATTCTTTATTTGTCTTTGTCTTTAT    
PBP4-expr-noSP-F  AAAACTGCAGTACTAACAGTGACGTAACCCCTGT 
construction of pBAD/HisD expressing His-PBP4 
PBP4-expr-noTM-R  CCGGAATTCTTAATGTTCTTCCCACATACTTTTAG 
PBP2A-expr-no TM-F TAATCCATGGCTTCAAAAGATAAAGAAAT 
construction of pBAD/HisA expressing PBP2a(no His-tag) 
PBP2A-expr-R TAATAAGCTTCTGTTTTGTTATTCATCTATAT 
potR-expr-F (for his & native) AACATAGGTAATAAAATTAAAAATCTTAGAAG 
construction of pBAD/HisD expression His or native PotR potR-expr-R (for expr and 
promoter fusion) CCGGAATTCCTATAAATATGAAGCTGTCGCTAC 
HisN- noSP-potD -FP                                GAACAAGTGCATACAAATCAAAAAATTTACG 
construction of pBAD/HisD expression His-PotD 
HisN-native-potD-RP CCCAAGCTTTTTATTTTAATGACATTTTGAA 
potR-arm1-F        CGCGGATCCCGGTGCTCAAGTAGTTGGTACTGG construction of pCN56 carrying PpotR and PpotRA::gfp fusion; construction of potRABCDE deletion 
PpotR-R         CCGGAATTCACGTTCAGCAAGTTCTTCTTGCG  construction of pCN56 carrying PpotR::gfp fusion 
potR-expr-R CCGGAATTCCTATAAATATGAAGCTGTCGCTAC construction of pCN56 carrying PpotRA::gfp fusion 
potR-arm1-R        CGACCTAGGACGTTCAGCAAGTTCTTCTTGCG  
construction of pMAD/CM∆potRABCDE  potD-arm2-F         CCGCTCGAGAATCATAAATAGTAGTTATTTACTG 
potD-arm2-R GGAAGATCTCACATCATAATAATCATCTTTCGG 
tetM del-arm1-F CGCGGATCCCGGACTACCAACCCAAACAGCTAG  
construction pCN38/tetM 
tetM del-arm2-R GGAAGATCT TTAGAGCCGTTGGTTTAGCGATTA 
speG-F     CGCGGATCCTGCTGCTCTAGTTTTCACTTCCAAC 
construction of pCN38/speG 
speG-R CCGGAATTCGAAGTAATTCAGGTTTGAACCTACC     
gyrB-F         TTAGTGTGGGAAATTGTCGATAAT 
qRT-PCR 
gyrB-R AGTCTTGTGACAATGCGTTTACA 
potA-F AATATTGTTGAAGGGCGCAT 
potA-R TTCTGGTCGAATAACGACTTCT 
tetM-F  ACAATCCGTCACATTCCAAC  
tetM-R TTGGGAAGTGGAATGCAGTA  
kdpA-F     ACGAGTACATCGTCATGCGT 
kdpA-R CTGCTCCAAACCGTACCTCT 
Table S1 Oligonucleotides used in this study.  
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RN1-FP CTGCATTTAGATAATTTAGTTGGG 
confirmation of mutation site, trkA 
RN1-RP CGCAACATTATGCGCAATACGTCTACCC 3’ 
RN2-FP GCTGGTAAATCCATTTCTTCACC 
confirmation of mutation site, sigA 
RN2-RP CTGAATCCAAGTGATCTTAG TGCC 
RN3-FP CCAAGACGATGTGCTAATGGTGC 
confirmation of mutation site, relA 
RN3-RP GGCGAAGTAATAAATATGAATGGG 
RN4-FP GGCACATCAATAACCAAGGCG 
confirmation of mutation site, atpG 
RN4-RP GTCAGCGTTCTTGAAAACAAGCC 
RN6-FP GCTCTCTTTACTTACCATATAATGGC 
confirmation of mutation site, fbp 
RN6-RP CGAATGAATTATACAATAGTGTATAGCC 
Mu-FP GGTTTAGTTGCTATATCTGGTGG 
confirmation of mutation site, pbpB 
Mu-RP CGCGTTGTTATAAGTACCACCG 
704394-FP CGAACAGCTGCTTCTCTTTGAACG confirmation of mutation site, intergenic region of SAV0631-
SAV0630 704394-RP TAGCCACACTCATATGACATCGG 
XY1-F  CGCG GAT CCT AGA TAA TTT AGT TGG GGT AC 
construction pCN33/(m)trkA 
XY1-R CGCGA ATT CTG TCC CAC TCC CGA TTA TCT CG 
XY2-F CGCG GAT CCT AGT TAC CGC ATT TAA ACA AC 
construction pCN33/(m)sigA 
XY2-R CGCGA ATT CGC GCT TAT TCA TGT CTT GGT ATC 
XY3-F CGCG GAT CCA TGA AAC AGT AGA TTT AGG TCG  
construction pCN33/(m)relA 
XY3-R CGCGA ATT CCA CCT CTA GTT CCA AAC TCT TG 
XY6-F CGCG GAT CCC CTA ATA CCA AAA TCC TGC CC 
construction pCN33/(m)fbp 
XY6-R CGCGA ATT CCA CGA TAC ATG CAT CAA ATG TCG  
XY4-F1 CGCG GAT CCA CCA AGC GAT TTC TGA GG 
construction pCN33/(m)atpG 
XY4-R11 GCG AAG CTT GTT GTA GAA ACG ACT CAT 
XY4-R12 GCG AAG CTT GAG CGG GGA TTT GTG ATC 
XY4-F2  GCG AAG CTT GCT TCT CTT AAA GAA ATA G 
XY4-R2 GCCGA  ATT CAT TCC CAT GCT ATT TTC CTC 
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Table S2 Transcriptome: MuM vs Mu50 (no Spm) 
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Table S3 Transcriptome: Mu50 low Spm. Ox. Spm+Ox (Assay I) 
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Table S4 Transcriptome: Mu50 high Spm (Assay II) 
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Table S5 Transcriptome: RN4220 vs its SpmR mutants (no Spm) 
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APPENDIX B: CHARACTERIZATION OF SPM SPONTANEOUS RESISTANT MUTANTS 
In addition to MuM as characterized in Chapter 2, nine more Spm-resistant mutants were independently 
isolated from agar containing Spm at 8x MIC or higher at a frequency of 1x10-8: three strains from 
RN4220 (MSSA; a common lab strain), one from Mu50 (MRSA) and five from COL (MRSA). To further 
investigate the molecular basis of Spm resistance, the phenotypes and genotypes of those SpmR mutants 
were characterized and described below. 
Increased resistance to β-lactam/Spm synergy among SpmR mutants 
MuM and nine more SpmR mutants were further tested on their susceptibility to Spm and synergy. In 
comparison to the their parental strains, all mutants exhibited 32-64 fold increment on Spm MIC, 
regardless the growth conditions for MIC measurements (Table B.2). Notably, all these mutants also 
displayed greater resistance to Spm/β-lactam synergy although they were selected under Spm-only stress. 
The correlation between Spm resistance and synergy resistance existed universally among those SpmR 
mutants regardless their strain background or genetic modification(s).  
 
Growth phenotypes of the SpmR mutants  
The lack of PBP2 TPase domain impaired dramatically the growth/fitness of MuM. In order to see 
whether other SpmR mutants shared similar characteristics, we analyzed the growth phenotypes in the 
following aspects: 1) the growth rate in Spm-free LB; 2) the growth behavior in response to Spm; 3) 
whether the supplement of glucose can restore, if any, the growth deficit; 4) whether the growth deficit, if 
any, is related to Spm resistance. 
 
When incubated in theLB medium, three SpmR mutants-RNM6, COLM2, and COLM7- showed impaired 
growth, with great reduction on final yield and slight decrease on growth rate (Table B.1). Glucose 
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supplement in the LB medium can improve the growth by reducing the doubling time and increasing the 
final yield (Figure B.1).    
 
Next, growth kinetics in response to Spm were recorded in three RN4220 derived mutants (RNM2, 
RNM4, RNM6). In comparison to RN4220, the growth rate of RNM2 and RNM4 was hardly affected by 
Spm while RNM4 showed similar behavior as the parent. But even so, RNM4 still displayed high 
tolerance to Spm when incubated for long period as evidenced by the MIC measurement (Table B.2). This 
seemingly contradictory observation may indicate a unique defense mechanism of RNM4 to Spm toxicity. 
 
Identification of mutation sites in SpmR mutants 
To further evaluate the molecular basis of Spm resistance, several SpmR mutants derived from either  
RN4220 or Mu50 were subjected to genome sequencing .  Genomic DNA was extracted by the 
phenol/chloroform method and DNA sequencing was conducted by 454 pyrosequencing. Plausible 
mutations were identified from sequence comparison and further  confirmed by PCR-based sequencing 
aslisted in Table B.3.Interestingly, although those mutants were isolated independently, two mutations 
were shared between different variants: R153L at SigA, and D67E at RelA in both RNM2 and RNM4.   
For the Mu50 derivative, MuM3, only one mutation at the intergenic region of mntC and tnp (transposase ) 
was identified in this study. 
 
Complementation 
In order to see whether the identified mutations are responsible for Spm resistance, each candidate gene 
(including its ORF and upstream regulatory region) was amplified from wt and mutant genome, 
individually cloned into E. coli-S. aureus shuttle vector pCN33 (copy number  10-15), and transformed 
into either wildtype or corresponding SpmR mutants.  Table B.4 showed the complementing plasmids 
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constructed so far, and most of these plasmids were successfully introduced in S. aureus strains. For sigA 
and atpG, even after many trials, no transformants can be obtained. 
 
Next, to understand the role of the candidate genes in Spm resistance, the Spm MIC was determined in 
those recombinant strains. For those tested strains, as revealed by Table B.5, their susceptibility to Spm 
didn’t show any changes regardless of the wt or mutant genes introduced. Since only one but not all 
mutations was complemented in those transformants, how the candidate genes contribute to the resistance 
remained unclear, and the possibility of combinational effects by multiple mutations cannot be ruled out.  
 
Transcriptome analysis 
To obtain a comprehensive view on how these mutations affect the transcriptome, the gene expression 
profiles of RNM2, RNM4, and RNM6 (derived from RN4220) -were analyzed by DNA microarrays 
(Affymetrix GeneChip). Incomparison to their parents, 178, 21, and 108 genes showed significant 
changes (with >2.5 fold change and signal intensity >200) in RNM2, RNM4, and RNM6, respectively. 
Notably, consistent with the similar growth behavior with its parent RN4220, the expression profile of 
RNM4 showed the least changes, with only 21genes down-regulated. Notably, unlike sigA and relA 
which were present in both RNM2 and RNM4, mutation on trkA was unique to RNM2 while the 
transcriptomes of RNM2 and RNM4 were vastly varied. Therefore,  trkA may play an important role in 
regulating the transcriptional changes in RNM2, and possibly the resistance to Spm. 
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 Table B. 1 Summary of SpmR mutants selected from different lineage of S. aureus 
 
Mu50 (MRSA), RN4220 (MSSA), and COL (MRSA) are parental strains sensitive to Spm and Spm/β-lactam 
synergy. S, sensitive; R, resistant. 
 
 
Table B. 2 MICs of Spm or β-lactams in SpmR mutants 
 
1β-lactams used in the combinational treat: oxacillin for Mu50 and its derivatives; ceftazidime for RN4220 and its 
derivatives. 2 Spm concentration used in the combinational treat: 0.5mM for Mu50, RNN4220 and their derivatives; 
0.1mM for COL and its derivatives 
 
Strain Spm susceptibility
β-lactam/Spm 
susceptibility
Growth phenotype (LB)
generation 
time (min)
final yield 
(OD600)
Mu50 S S 35 4.6
MuM R R 127 1.4
MuM3 R R 37 4.5
RN4220 S S 24 4.9
RNM2 R R 30 5.1
RNM4 R R 29 4.6
RNM6 R R 33 2.1
COL S S 42 3.2
COLM1 R R 45 3.1
COLM2 R R 53 0.8
COLM5 R R 40 3.1
COLM6 R R 44 2.8
COLM7 R R 56 0.9
Spm β-lactam1
broth, no 
shaking
broth, 
shaking
agar 
plate no Spm Spm
2
Mu50 2 2 4 512 0.5
MuM 32 64 64 512 512
MuM3 >64 ND ND 512 512
RN4220 4 4 4 8 <0.01
RNM2 8 64 64 8 16
RNM4 32 64 64 8 8
RNM6 16 64 64 8 16
COL 0.25 ND ND 256 <0.5
COLM1 16 ND ND 512 512
COLM2 16 ND ND 512 512
COLM5 16 ND ND 512 512
COLM6 16 ND ND 512 512
COLM7 16 ND ND 512 512
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Figure B. 1 Glucose effects on the growth deficient SpmR mutants. 
Growth deficient mutants: MuM, RNM6, COLM2, and COLM7 
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Wildtype: Mu50, RN4220; SpmR mutants: MuM, RNM2, RNM4, RNM6 
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Figure B. 2 Growth kinetics of wildtype and SpmR mutants on exposure to Spm 
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Table B. 3 Mutations identified in SpmR mutants 
 
 
 
 
Table B. 4 Summary of complementation experiments. 
 
wt, wildtype copy of candidate gene; mt, mutant copy of candidate gene 
+, done or yes; -, not done or no.  
e.g. the both wildtype and mutant copy of trkA have been cloned and transformed into either wildtype host or mutant 
host. The plasmid-borne wt trkA cannot restore Spm sensitivity in RNM2 (having trkA mutation on chromosome); 
likewise, the plasmid-borne mutant trkA was unable to make RN4220 become resistant to Spm.   
 
 
 
 
  
ORF ID Gene and Protein Name
Protein 
Sequence 
Length
Mutation Type
Mutation 
Presented 
Mutants
Parent 
Strain
SAV1450 pbpB, PBP2 727 7-bp deletion in TPase domain, after F455 MuM Mu50
Intergenic region, 
downstream of SAV0631(mntC), upstream of SAV0630(tnp) - C to A MuM3 Mu50
SAOUHSC_01034 SA0939, Hypothetical protein 
(similar to TrkAK+ uptake family) 220 CAT to TAT(H47Y) RNM2 RN4220
SAOUHSC_01662 sigA, RNA polymerase sigma factor RpoD 368 CGT to CTT(R153L) RNM2,RNM4RN4220
SAOUHSC_01742 relA, GTP pyrophosphokinase 736 GAC to GAA(D67E) RNM2,RNM4RN4220
SAOUHSC_02343 atpG, F0F1 ATP synthase gamma chain 288 ACT to CCT(T228P) RNM6 RN4220
SAOUHSC_02822 fbp, Fructose-1,6-bisphosphatase class 3 654 ATG to ATA(M493I) RNM6 RN4220
trkA sigA relA atpG fbp
wt mt wt mt wt mt wt mt wt mt
Correct construct in E.coli + + + - + + + - + -
Transformed into S. aureus + + - - + + - - + - (in puc18)
Complemented - - NA NA - - NA NA - NA
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Table B. 5 MICs of Spm in wildtype, SpmR mutants and complementing strains. 
                            
                              mtrkA, mrelA, mutant copy of trkA, relA 
 
 
 
 
 
 
Table B. 6 Statistics of 454 genome sequencing. 
Performed using 454 GS FLX system (in 2009) or GS Junior (in 2012) 
 
Strain Spm MIC (mM)
RN4220 4
RNM2 64
RNM4 64
RNM6 64
RN4220/mtrkA 4-8
RN4220/mrelA 4-8
RNM2/trkA 64
RNM2/relA 64
RNM4/relA 64
RNM6/fbp 64
Mu50 MuM MuM3 RN4220 RM2 RM4 RM6
Sequencing system GS FLX system GS Junior GS FLX system
Reference sequence NC_002758 NC_007795
Num. Reads: 35180 39901 201155 26880 28333 35008 39915
Num. Bases: 13105328 15109299 83723458 9542418 10031840 13054399 13837616
Mapped Reads: 34398 
(97.66%)
38927 
(97.44%)
198178 26832 
(99.67%)
28253 
(99.53%)
34916 
(99.57%)
39864 
(99.75%)
Mapped Bases: 12819807 
(97.81%)
14732960 
(97.50%)
82914115 9506674 
(99.61%)
9994602 
(99.60%)
13010233 
(99.64%)
13796679 
(99.69%)
Ref genome size(bp) 2878529 2821361
Avg. Map Length 373 379 418 355 354 373 347
# of contigs 509 353 842 757 448 372
Avg. contig size 5483 7953 3052 3410 5857 7093
Min. contig size 101 116 100 124 103 103
Max. contig size 42330 89033 2841620 20527 38706 38685 48360
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